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In healthcare, documentation deals with recording of significant patient encounters within a 
healthcare information system. Documentation has evolved from paper-based tools to electronic 
means such as Electronic Health Record (EHR) systems. The EHR may optimize healthcare 
processes by facilitating communication, offering decision support, and allocating and 
distributing resources to health facilities for patient care. Faced with the Human 
Immunodeficiency Viruses that leads to the Acquired ImmunoDeficiency Syndrome 
(HIV/AIDS) pandemic, Malawi has embraced an EHR for its Anti-Retroviral Therapy (ART) 
clinics since 2006. The 90-90-90 HIV/AIDS eradication strategy which Malawi adopted with the 
leadership of the World Health Organization (WHO) United Nations against AIDS (UNAIDS) 
may benefit from this EHR. In this initiative, identification and enrollment of HIV positive 
clients into ART clinics is essential for viral load suppression.  The EHR benefits rely on good 
data quality, which has been lacking in Low-Income Countries (LICs) including Malawi. 
Although data quality has many definitions, a widely accepted concept is “data quality is fit for 
purpose.” This concept has not been used in many data quality assessments, particularly in LICs. 
I asked the following research question:  
How can the varying purposes of EHR data use for different stakeholders inform interventions 
for EHR data quality improvement? 
I had the following research aims: 
• To understand the importance of data quality characteristics in the context of EHR 
stakeholders’ purposes of data use  
• To conduct a data quality assessment and understand the drivers of the observed data 
quality  
I conducted this research at primary, secondary and tertiary level ART clinics that manage over 
200 patients a day in Malawi. 
My study used an observational study design with mixed methods. I conducted semi-structured 
interviews with 34 stakeholders comprised of nurses and clinicians as well as public health 
xii 
officials and donors who support the EHR. Additionally, I assessed 160,647 patient records that 
had 549,826 visits across 10 different health facilities, extracted from existing EHR data.  
My work established that stakeholders have clinical facing purposes or administrative purposes 
of data use. Stakeholders with clinical facing purposes of data use expected their data to be 
plausible.  On the other hand, stakeholders with administrative purposes of data use expected 
completeness first. I found variation in the observed proportions of the data quality 
characteristics of completeness and plausibility. Completeness ranged from 5% to 99% while 
plausibility ranged from 40% to 99% across variables essential to the 90-90-90 initiative. After 
integrating my qualitative and quantitative results, some results indicated agreement or 
convergence between different sources of information about data quality.  
Data quality was high for the preferred characteristic of plausibility for patient health tracking. 
Conversely, there were divergent results between findings in my first and second aims for data 
management and use. For this purpose of data use, I found that plausibility was highly prioritized 
by participants, but in the data assessment, I found that only 40% of the records were plausible.  
The recommendations that follow from my work regarding interventions to improve data quality 
include: 
• Consider priorities based on importance of specific data quality characteristics for 
different stakeholder purposes of data use. 
• Assess observed data quality proportions after conducting a quantitative data quality 
assessment to identify where interventions should first be implemented in relation with 










Many countries and health systems in the world continue to adopt electronic health records 
(EHR) as tools for documentation and facilitating patient assessment, patient care, and public 
health programming (1,2). EHRs have been implemented in high income countries (HICs) and in 
low- and middle-income countries (LMICs) (3). The implementation of EHRs is based on the 
hope of reaping some primary benefits of use that computerized systems promise such as better 
storage of information and easier computations, to secondary uses in healthcare such as 
facilitating better decisions by providing computerized clinical decision support for health care 
providers and hence better patient outcomes (4,5). The implementation of EHRs may also lead to 
secondary benefits of data use such as the better management of health resources such as medical 
drugs and other medical commodities by providing automated reporting (4,5). These benefits 
may result in the support of the design of health interventions that reduce patient morbidity and 
mortality.  
These benefits, however, have hardly been realized despite the implementation of EHRs due to 
various challenges.  
Some challenges reported concern EHR infrastructure due to limited power supply that leads to 
power failures, limited communication technology that leads to inability to transfer data across 
health facilities, and inadequate capacity of human resources that may lead to improper use of 
the EHRs (1).  
Another challenge in the developing world is the source and amount of funding for implementing 
EHRs (10). The sources of funding usually have specific strategic goals and limited amounts of 
resources targeting their strategic goals that are usually specific diseases. This leads to 
fragmented EHR infrastructure from the beginning (7,11). This focus on disease specific EHRs 
may be observed from funding opportunity announcements of major donor funding organizations 
and programs such as the Centers for Disease Control and Prevention with programs such as the 
President’s Emergency Program for AIDS Response and the President’s Malaria Initiative. The 




Child Health Interventions. The disease-focused EHRs usually lead to data silos and missing 
critical data for healthcare providers to use in their various roles. It may also lead to redundant 
documentation of patient encounters with the healthcare system, and thus lead to longer waiting 
times for patients at facilities.  
Nevertheless, the developing world needs EHR investments to effectively tackle some of the 
disease burdens, which in most cases are global emergencies, such as the HIV/AIDS pandemic 
(3). Consequently, most of the EHRs developed and implemented in the developing world, 
particularly sub-Saharan Africa, have focused on HIV/AIDS program monitoring and evaluation. 
In health facilities that have implemented EHRs for some time in the developing world, there 
have been additional reported challenges to the ones mentioned above, such as poor data quality 
(12). Data quality may have different definitions and interpretations, depending on the data 
quality framework chosen to measure it (13). One perspective is that data quality should be 
defined with consideration of the purpose of use of any data whose quality is being examined 
(14). This perspective brings in the view that data quality is fit for purpose. Poor data quality 
directly defeats the benefits of EHRs at the patient and population levels. For example, poor data 
quality is a barrier to decision support. Poor data quality is also a barrier for national program 
strategic goals such as the proposed 90-90-90 HIV/AIDS eradication goals (78).  
This strategic goal first proposed by the UNAIDS and the WHO has been adopted by many 
governments including in the developing world. The 90-90-90 HIV/AIDS goals include (78):  
• Identifying 90% of a country’s population that is HIV positive via HIV diagnostic tests;  
• Making sure that 90% of the identified HIV positive population is enrolled in care and 
retained in care accessing anti-retroviral (ARV) therapy treatment; and lastly,  
• Making sure that 90% of the maintained population achieve viral load suppression. The 
recommended viral load for patients to remain healthy and reduce morbidity due to HIV 
opportunistic infections, is below 1000 copies/ml (77) and this is considered viral load 
suppression.  
In the case of EHRs being implemented for HIV/AIDS management, poor data quality has 
severe implications for monitoring progress toward the 90-90-90 targets (15).  
My study addresses the problem of poor EHR data quality in Anti-retroviral Therapy (ART) 
clinics for HIV/AIDS, as reported in Malawi (9). It builds on the rich body of literature of a 




study conducted in Malawi identified missing data as a barrier for providing audit and feedback 
reports of specific clinical practice guideline recommendations to healthcare providers (9). 
Similarly, a study in Haiti assessed data quality in selected health facilities in Haiti and found 
poor data quality based on the characteristic of completeness. The completeness for variables 
such as weight, height, and ART pregnancy status was measured in the range of 20% to 40%. In 
a follow-up study also in Haiti, the researchers presented a process for identifying variables to 
prioritize and implement with an intervention of automated audits (16). In their process, they 
suggested audit and feedback as an intervention for improving data quality prior to considering 
data quality characteristics in relation to stakeholder purposes of data use and the priority they 
would attach to a data quality characteristic.  
My work examines electronic data quality to identify factors to consider when selecting 
interventions to improve it. These factors have the potential to increase the benefits of EHR use 
in meeting national priorities such as the 90-90-90 targets for HIV/AIDS eradication in Malawi.  
To begin investigating the challenge of data quality, I present “Background and review of the 
literature,” in Chapter 1, where I provide definitions used in my study and discuss the state of 
EHR implementations in low-income countries (LICs). With my health infrastructure and 
learning systems background, I also discuss how my research fits into concepts of learning health 
systems and infrastructure. I introduce my research question and aims as well in this chapter. I 
also explain the data quality frameworks used in my study. 
In Chapter 2, I describe my study methods. I used mixed methods to compare results for 
qualitative aims to my quantitative aims with an appropriate integration strategy. The methods 
include the data collection and data analysis plan for my research. The perspective I adopted for 
my research is that data quality is “fit for purpose.”  
Chapter 3 presents the qualitative findings and the quantitative results of my study, where I 
establish that different stakeholders have different purposes of data use and attach different 
priorities when it comes to data quality characteristics that they expect in the data that they use. 
This chapter also presents my quantitative data quality assessment results, where I found poor 
data quality for some of the 90-90-90 variables, such as patient physical address completeness, 
which is necessary for patient health tracking, and patient drug adherence completeness data 
quality for monitoring how well patients are taking their drugs which is essential to achieve viral 




patient body mass index using weight and height and these are essential for routine patient care. 
A continuously declining BMI is a sign of treatment failure and may affect retaining these 
patients in care. 
In Chapter 4, I discuss how the differing priorities for data quality characteristics may inform 
interventions for improving data quality, including a procedure for identifying interventions for 
data quality improvement in low-income settings. 
The chapters above, together with the frameworks I chose for my study, help me answer the 
research question I present in Chapter 1: 










Chapter 1 Background and Review of Literature 
Background 
1.0 What is Documentation? 
Broadly, documentation is defined as the process of producing any proof in support of a fact(1). 
In healthcare, documentation deals with recording any details of a patient’s encounters with a 
healthcare system. These processes may include the patient’s history, clinical observations, 
diagnostic studies, medical history, clinical course or management, and any care-related 
outcomes and decision making(2). In the medical field, documentation has a long history that can 
be traced back to the Egyptian empire, where physicians recorded details of surgical procedures 
on papyrus(3,4). Such accounts of documentation almost 4,000 years ago emphasized the 
structure of the clinical documentation. This structure consisted of 4 main parts starting with an 
examination of the patient, moving onto diagnosis, then providing a suggested treatment, and 
lastly, a prognosis for the patient. Nowadays, a similar structure in documenting a patient 
encounter may be found with the addition of recommendations, such as uniquely identifying 
patients to allow for continuity of patient care, as advanced by global health organizations such 
as the World Health Organization (WHO)(5).   
The WHO has also recommended documentation mechanisms, such as the use of specific forms 
for particular healthcare services in Low and Middle-Income Countries (LMICs) to ensure 
quality in documentation(6). Recommended documents such as these have been adopted and 
adapted for different health organizations to enhance the quality of documentation. In addition to 
these forms, most national monitoring and evaluation programs have adopted indicators for 
measuring disease burden from the WHO. Specific variables need to be collected in order to 
report on these indicators. Examples of such indicators are those for measuring HIV/AIDS 
disease burden. These include indicators for prevalence or incidence of HIV/AIDS disease in 
different countries. Most countries measure these indicators by counting cases of HIV infected 
individuals and clinical or diagnostic reasons for patients being enrolled into HIV/AIDS 
programs plus the primary and secondary disease outcomes of the patients. The primary 
outcomes describe drug regimens that patients are on and respond to indicators such as health 




and patients that have been lost to treatment. Techniques such as cohort analysis are used to 
achieve these measurements(8). The forms proposed by the WHO and associated indicators have 
been adapted to come up with tools suitable for their different LMIC settings(9). These forms 
have been the basis for defining minimum data fields in EHR systems used in HIV/AIDS clinics. 
Given that the EHR may be used beyond documentation as infrastructure that may routinely help 
improve healthcare systems, I considered the role of the EHR in the context of a learning health 
system which could be a model for improving health processes and outcomes. 
1.1 The Learning Health System 
A learning health system is defined as a structure in which “science, informatics, incentives, and 
culture are aligned for continuous improvement and innovation, with best practices seamlessly 
embedded in the delivery process and new knowledge captured as an integral by-product of the 
delivery experience” (10). Although such systems are nascent in the developing world, 
discussions have begun around the improvements in health processes that learning health 
systems may bring in the area of health research(11). The discussions have focused on pooling 
data from several research institutions as a step towards enabling learning health systems. A 
learning health system may exist at any level of health interaction (12) and is enabled by a 
learning health cycle that requires an appropriate infrastructure. The underlying infrastructure is 
the support or base for the learning health cycle. The learning health cycle describes the 
transition of data in health settings into knowledge and the knowledge into performance for use 
in a learning health system (13).  
Support is generally defined as an underlying base or foundation for an organization or a 
network and is an essential component for a learning health system. Learning health systems 
may function independently but synergistically to deliver services to a community of 
stakeholders (14). For example, at a global level, each country may have an independent 
electronic health system as infrastructure. Still, these standalone systems may follow data 
exchange standards to synergistically respond to global needs via coordinating bodies such as the 
WHO. Examples of standards to allow this coordination are the indicator standards that different 
countries adopt for HIV/AIDS reporting (7). This would enable learning at a technical level of 
data. Additionally, there would be a need to have common practices and guidelines to enable any 
discovered knowledge identified to transition into improved performance at a people or society 




need to be conversant with these practice guideline recommendations. A common socio-
technical infrastructure that would have technical infrastructure via standards and socio 
infrastructure via clinical practice guidelines and recommendations may enable a learning health 
system. The HIV/AIDS EHR in Malawi is an example of such an infrastructure having 
embedded measures that contribute to national indicators and clinical practice guideline 
recommendations (15). I illustrate this concept of a learning health cycle with a common socio-
technical infrastructure in the figure below. 
 
Figure 1.1 Common Components of Socio-Technical Infrastructure in Malawi 
 
I discuss health documentation in the context of learning health cycle and health infrastructure in 
the next sections. Health infrastructure in the context of my study is represented by EHRs in 
ART clinics.  
1.1.1 Documentation in the Context of the Learning Health Cycle 
Documentation commences with the recording of facts, observations or impressions among other 
things and serving these in support of a phenomenon. Figure 1 illustrates my mapping of 
documentation processes in the context of my study to the learning health cycle. As can be seen, 
I map EHR documentation of health processes in Anti-Retroviral Therapy (ART) clinics for HIV 
in the Data to Knowledge section of the learning health cycle. This position is taken because my 




to inform interventions for improving data quality in the ART clinics. Furthermore, my 
qualitative study was again conducted to understand other factors that may influence data quality 
and therefore gathering data for further analysis into knowledge.  
 
 
Figure 1.2 Mapping of Study to the Learning Health Cycle 
1.2 What is the purpose of healthcare documentation? 
Documentation in healthcare promotes communication and coordination among health care 
providers, provision of evidence for patient assessments, facilitation of continuity of patient care 
and facilitation of the development of public health programs (16).  
Promoting communication and coordination has been highlighted in several studies where proper 
documentation has been shown to influence the quality of care delivered to patients in different 
settings. For example, one study in a maternity clinic in Senegal showed that documentation of 
postpartum hemorrhage at admission facilitated communication between health care providers 
and thus reduced adverse outcomes compared to cases where postpartum hemorrhage was not 
documented (17).   
Additionally, documentation provides evidence and context that health care providers may use to 
make decisions (16). In chronic illnesses such as HIV/AIDS, documented observations of 
continued weight loss over a long period may suggest the need to reconsider treatment options as 
this may be an early sign of treatment failure (18). In this case, documentation provides a basis 
for clinical reasoning and decision making (19).  
Continuity of patient care is another essential application for documentation with observations 




facilities (20). Proper documentation, in this case, may influence treatment outcomes as the 
patient may receive quicker treatment when accurate information is available.  
Documentation is also essential for facilitating public health programming via analysis of clinical 
records that are a result of documentation. Proper documentation can result in the adequate 
allocation of resources and, eventually, the implementation of public health programs. This use 
of documentation was particularly crucial for the Malawi national HIV program (21).  
Documentation in health is also traditionally used for medico-legal functions as a signed and 
dated medical record may be used for legal purposes. This purpose of data use has been 
emphasized by communities of practice, and an example is the American Speech-Language-
Hearing Association (ASLH) that has developed explicit guidelines so that the resultant 
documents may stand as evidence in a court of law when need be (22).  
Beyond the benefits of documentation mentioned above, additional interest for promoting 
documentation in health settings has been the desire to improve health care processes and 
improve patient outcomes. Documentation provides an opportunity to collect data that may be 
used to respond to specific indicators of quality of healthcare delivery. Thus, documentation may 
also be seen as a way to support primary and secondary data use in the context of ART clinics 
for HIV.  
1.3 Operational Definition of Documentation for this Study 
For purposes of this study, documentation is: 
A process of recording facts or use of recorded facts in an Electronic Health Record system 
(EHRs) about patients’ health during a patient and healthcare provider encounter by healthcare 
providers in ART clinics for HIV in Low-Income Countries (LICs).  
1.4 How is healthcare documentation conducted in different parts of the world? 
Healthcare data capture may take several forms ranging from handwritten notes on patient charts 
to the use of electronic media such as EHRs or automatically generated laboratory test results 
(19). Paper is the most basic form of documentation, requires little training and technology (23), 
and has been the form of documentation in healthcare settings for a long time. Unlike its digital 
counterparts, which can be limited by downtime due to technology failures, paper-based 
documentation tools have been considered reliable from an availability perspective (23). 
Despite the convenience of using paper-based tools for documentation in healthcare, advances in 




documentation. The problems include: the patient record being unavailable to multiple health 
care providers at the same time; data loss due to paper damage; legibility of hand-written patient 
records; passiveness of paper records which suffer from not being computable and hence not 
being able to incorporate automated reminders or alerts; privacy risks due to non-privileged 
access once in the open; and difficulty enforcing accountability due to lack of full chain of 
custody of the patient record(23). Technology has been developed to address some of these 
challenges, beginning with the development of electronic health records. These EHRs include 
building blocks such as Laboratory Information Management Systems (LIMS), Computerized 
Physician Order Entry systems, Picture Archiving and Communication Systems , Electronic 
Health Record systems (EHRs), mobile health applications (mHealth) and Civil Registration and 
Vital Statistics Systems (24).   
The applications above facilitate stakeholders’ primary data use. This use leads to data by-
products or secondary data uses, such as reporting for quality improvement programs and public 
health programming. These are examples of EHR benefits that go beyond the low-level benefits 
realized from technology, such as storage of patient records. 
The low-level benefits such as larger storage capacities for patient records and the prevention 
from damage due to natural events such as weather have been widely accepted and reported (24). 
However, high-level benefits, such as improving the quality of patient care processes and 
improved patient outcomes through techniques such as decision support, remain a work in 
progress (25). For example, an assessment of EHR deployments in the US observed that the use 
of EHRs to improve patient care processes and outcomes and reduce healthcare costs have not 
yet been reached (25). In attempting to solve this issue, high income countries (HICs) have 
exerted efforts to introduce process indicators that may help in measuring the benefits of EHRs. 
There have also been efforts to promote primary and secondary level use of data through 
establishing continuous patient care through new approaches such as learning health systems 
(13).  
Unlike in the U.S., EHRs in LMICs have mostly been implemented through donor support (26). 
Most of these EHRs have been program focused, being implemented for specific diseases such 
as malaria, tuberculosis, and HIV/AIDS (22). Additionally, the type of EHRs in LMICs is 
influenced by the overall cost of implementing technology in these settings. Therefore, most 




Information Technologies (HITs) in 16 LMICs showed that mHealth technology projects 
comprised 71% of the technology implementations, while 29% were computer-based (27).   
Public health reporting and programming also drive most of the EHRs in these LMICs, with the 
data being collected influenced by major local government bilateral partners (28). For example, 
in 2007, the Ministry of Health (MoH) and its partners made the recommendation to deploy an 
EHR in Malawi for the HIV/AIDS sector after they observed data quality challenges while 
manually compiling routine reports (15,21). 
I identified themes such as the scale of implementation, policy for application, integration among 
implemented EHRs in different settings, funding mechanisms, and business models that enabled 
implementation of the different EHRs and different designs of the HITs as characteristics to 
describe the implementation of EHRs in HICs and LMICs (15,25,26,29–31). I summarized the 
characteristics across the various economic settings in Table 1.1 below. 
 
Table 1.1 Comparison of Implementation of HITs in HICs and LMICs 
HIT 
Characteristic 
High-Income Countries (HIC) Low Middle-Income Countries (LMIC) 
Scale Usually hospital-wide and national Disease-specific and program-oriented 
Legislation Often through act of parliament and 
other policy documents 
Missing, or eHealth strategies or policy initiatives 
through government departments 
Integration Multiple vendors, health 
information exchanges 
Multiple implementers, some have a Master Patient 
Index (MPI) but missing in most countries. 
Funding Government-funded mostly Donor funded mostly 
Design Off the shelf mostly (Pre-built but 
customizable to health facilities) 
Custom-built using open source tools. Usually, 
regional focus. 
Data Use Combination of primary and 
secondary data use. 
Mostly for secondary data use such as program 
reports 
 
Despite varying levels of EHR and developments such as the challenges in different healthcare 
settings, the discussion above shows that EHRs are a mechanism for documentation and a tool 




1.5 Examples of EHR deployments as Health Infrastructure in the LICs 
I conducted this study with a focus on EHRs in Anti-retroviral Therapy (ART) clinics in Malawi. 
I therefore reviewed EHR implementations in similar settings. Seventeen out of 34 LICs have 
reported the existence of some sort of Health Information Technologies (HIT) to the WHO as of 
2018(32). Some examples of LICs that have adopted HIT in addition to Malawi are Haiti, 
Rwanda, and Kenya. I reviewed the implementations in these countries through publications that 
have described how the EHRs are implemented. I found that several non-profit organizations led 
disease-focused EHR implementations. HIV/AIDS is the leading disease around which the EHRs 
have been developed (26).   
Other LICs such as Haiti have also implemented EHRs in ART clinics to manage patients with 
HIV (33). The implementation in Haiti has evolved from collecting patient data on paper forms 
and retrospectively entering these into the EHR by data entry clerks, to a real-time point of care 
EHR where documentation of the patient encounter is done directly by healthcare providers (33). 
Despite managing over 150,000 HIV positive patients, the MoH in Haiti and other stakeholders 
have expressed concern over the data quality in the EHR that led to data quality assessment 
efforts being initiated in the country (34). In these efforts, stakeholders were asked to prioritize 
variables that were selected for automated data quality assessments in the Haiti EHR that was 
being used in ART clinics for HIV (35).  
Although not a LIC, but rather a Lower Middle-Income Country, Kenya has also implemented an 
EHR in ART clinics for managing HIV/AIDS patients called KenyaEMR (36). I discuss this 
implementation because of the similarity in the motivation for implementing the EHR in ART 
clinics for HIV in Kenya as in other LICs. This motivation is to improve patient health and 
program monitoring and evaluation (22).  Although the EHR in Kenya was implemented in over 
340 health facilities at the time of this study, there were reports of data quality challenges. For 
instance, a study that was conducted to assess completeness and concordance of selected patient 
observations before and after implementing the EHR found that health facilities that had 
implemented the EMR for more than 12-15 months were 1.31 times more likely to have missing 
data than those that had the EMR implemented for 5-8 months. Thus, there was a decline in data 
quality over time of the implementation in the Kenya setting. The study observed that poor data 
quality is a threat towards achieving benefits of the EHR, such as public health reporting and 




The Malawi EHR has mainly been implemented to manage patients enrolled in ART clinics to 
improve documentation and the care process (15) by providing guideline-recommended 
reminders and alerts at the point of care. The EHR implementation in the country manages 50% 
of all patients alive and on treatment.  
Despite the successes reported in Malawi, such as engineering solutions to power outages (15) to 
address infrastructure challenges reported in similar settings, poor data quality is a challenge that 
was identified as a barrier to implementing some interventions that may improve patient care via 
the EHR (38). Another study directly assessed the agreement of paper-based patient register 
records versus EHR records in Malawi (39). The study found that out of 31,763 patients 
registered in the EHR, only 28,359 (89%) were found in the paper-based registers. The study 
also found significant differences in patient death outcomes at two of the five health facilities. 
These two findings confirm the challenges in data quality in the ART clinics. The study did not, 
however, attempt to understand how the observed data quality related to any purposes of data use 
of stakeholders in the study sites. Instead, it was a measure of intrinsic data quality alone (40). 
Intrinsic data quality only measures the proportions of selected data quality characteristics 
without taking into consideration any contextual factors that may have affected the observed 
numerical data quality measures. 
I therefore aimed to understand data quality in Malawi and the perspectives of stakeholders and 
how these correlates to the actual quality attributes observed in the data. From this information, I 










1.6 The EHR Health Infrastructure in Malawi 
1.6.1 About Malawi 
Malawi is a landlocked country with a high population growth, which grew from 13 million, as 
reported in the country’s 2008 census, to 17.5 million in 2018(41). The country’s population is 
young and energetic to work towards the development of the country. The country is a 
biodiversity hotspot, home to Lake Malawi, 
the 3rd largest freshwater lake in Africa(42). 
The country’s economic backbone is 
agriculture. The farmers are hardworking, 
but productivity is hampered due to the use 
of primitive farming methods and lack of 
access to competitive markets for their 
produce. The main cash crop of the country 
is tobacco, which is facing a decline on a 
global scale due to smoking cessation 
campaigns (43). The country has not 
identified a viable alternative cash crop. 
These factors contribute to reduced social 
and economic indicators with about 70% of 
the country living below the poverty level, 
which is less than $1.90 per day (44,45). 
Despite growing urbanization, the country’s 
majority of the population has remained in 
rural areas where poverty is the highest (41). 
Malawi has made progress in the education 
sector with the introduction of free primary 
education (46) but has experienced 
stagnated growth in economic levels through poor infrastructure and limited industries to spur 
economic growth for the nation.  
The country faced a debilitating HIV/AIDS epidemic which began in 1985 when the first 
HIV/AIDS case was diagnosed (47). When HIV/AIDS prevalence in pregnant women rose to 
30% in 1992, the government established national strategic plans to tackle the epidemic. Actions 




taken resulted in the development of a national AIDS commission responsible for educating the 
country about HIV/AIDS and coordinating other programs to minimize transmission of the virus, 
such as the distribution of condoms (47). The HIV/AIDS epidemic exerted a significant burden 
on the health system, with the pressure created on human resources of all sectors, including the 
health sector (48). Additionally, to address the epidemic in its early stages, the country set up a 
public health response by adopting a simplified HIV/AIDS treatment approach so that many 
people in need of medication could access treatment (49). 
Government actions have resulted in many people accessing therapy, with 80% of the population 
living with HIV being on treatment (50). Holistic approaches to voluntary testing and treatment 
have also resulted in a current HIV prevalence of 9.2% (51). Although this is still high, it 
represents tremendous progress, considering that the prevalence was around 15% at the 
beginning of the scaling of HIV treatment in 2004(52). To support efforts of fighting the 
HIV/AIDS scourge, the country has also received development assistance from foreign 
governments and non-governmental organizations, leading to further improvements in tackling 
HIV through the adoption of new policies such as “test and treat” (53).  
The country set up a monitoring and evaluation system using a cohort analysis method and 
implemented via quarterly health facility supervision visits that count the number of patients that 
are alive and require treatment. This activity takes place in over 800 health facilities in the 
country (8).  
The 800 health facilities are part of a public health system which is organized into three main 
levels:  
● Primary care health levels which translate into health posts, rural health centers, and 
urban health centers; 	
● Secondary health levels that comprise community hospitals, rural hospitals, and district 
hospitals; 	
● Tertiary hospitals that comprise central hospitals. 	
	
Patients are referred up the three levels above, depending on the severity of the presenting 
condition (54).  
The health system also has missionary hospitals that are organized by religious denominations, 
the largest being the Christian Health Association of Malawi (CHAM). The country has some 
private health facilities; however, the most significant health provider remains the government 




The monitoring and evaluation requirements increased with the growing number of patients and 
a recommendation on implementing an EHR (8). The EHR has been implemented in the country 
starting in 2007 (15). Over 750,000 patients were on treatment in these 800 health facilities at the 
end of 2017. 50% of whom are managed using the EHR. The EHR is thus an important part of 
national HIV/AIDS strategic goals such as the goal to eradicate HIV/AIDS by 2030 using the 90-
90-90 strategy which Malawi adopted with the leadership of the World Health Organization 
(WHO) United Nations against AIDS (UNAIDS). In this initiative, identification and enrollment 
of HIV positive clients into ART clinics is essential for viral load suppression.  The EHR 
benefits rely on the availability of data of good quality, which has been lacking in some LICs 
including Malawi. 
1.6.2 Malawi EHR Infrastructure 
The EHR is a web-based application that was designed and developed using open-source 
technologies on behalf of the Malawi MoH. The application is available online on GitHub to 
help diffuse the software to other parts of the region (55). The EHR also has hardware innovation 
that takes into consideration constraints such as limited power supply from the national grid 
supplier; and the low computer literacy among health care providers in the country. To address 
these challenges, the resultant technologies have been low power consumption technology whose 
devices are powered by solar batteries using direct current. Touchscreen user interfaces are used 
to enhance the usability of the EHR across healthcare providers who have usually not interacted 
with EHRs before (15). 
The EHR in Malawi was implemented for scale in 2006, and each patient record is first 
documented in the EHR. The visit details are summarized and printed on a sticky label that is 
pasted on specially designed patient charts as a backup of the electronic record (15).   
Driven by a desire to impact the care delivery process, the MoH insisted that the EHR developed 
for the country should embed guideline recommendations so that while documentation is being 
conducted through the EHR, reminders or alerts would appear to health care providers to 
improve adherence to the clinical practice guideline recommendations (15). The system has thus 
recognized clinical practice guideline recommendations although the knowledge has been 
hardcoded in the EHR (56).  The national guideline recommendations in the EHR were shown to 
be auditable, where it was found that a performance measure could be defined for the 




be computing a proportion of patients that have a drug-induced side effect as a denominator with 
the numerator as patients that had their regimen changed reduce side effects, based on the 
guideline recommendation. 
The observation that the EHR data are auditable means that the EHR may be used to support 
other interventions for patients such as meeting milestones for viral load monitoring and 
enforcing adherence to clinical practice guideline recommendations for other conditions. These 
guideline recommendations include giving counseling to patients based on how adherent they are 
to taking medications. This guideline recommendation implemented via the EHR is an example 
of primary data use via the EHR.  
The EHR data may also be used for secondary data uses via facilitating programs such as “back 
to care” that trace and find patients using patient address data and bring them back to the health 
facility when they miss scheduled appointments. These applications fall in the country’s broader 
effort adopted from the WHO and the UNAIDS that focuses on identifying 90% of the 
population that is HIV positive, getting 90% of this population into care, retaining them under 
care, and making sure that 90% of this retained population has viral load suppression (58). Table 
1.2 below is an example of how the EHR in Malawi maps to the 90-90-90 eradication goals:  
Table 1.2 Mapping EHR modules to the 90-90-90 HIV eradication targets 
90-90-90 Goal Mapping to EHR Description 
First 90 – Identification 
of all people that are 
HIV positive 
HIV testing services 
module 
This EHR module guides healthcare providers into the 
processes of HIV testing and counseling following national 
clinical practice guideline recommendations. It assigns unique 
patient identifiers to all clients regardless of the HIV status 
after trial. Generates national reports for public health 
planning. 
Second 90 – Enrollment 
of all HIV positive 
patients into ART clinics 




ART EHR module Assigns unique IDs to HIV positive patients that do not have 
unique IDs yet; Maintains the ID for those that are already 
positive; guides healthcare providers to manage the patients 
according to national clinical practice guidelines. 
Recommendations such as drug adherence, viral load 
monitoring, among others. Generates national reports for 
public health planning.  
Third 90 – Viral load 
tracking and reporting 
National Laboratory 
Information 




ART EHR module 
 
Tracks all diagnostic requests for patients enrolled in ART 
clinics by accepting lab orders from ART clinics and guiding 
laboratory technicians and managers through the testing 
process. Generates national reports for public health planning. 
 
Gives alerts on viral load milestone and facilitates sample 
ordering via the EHR 
Receipt of viral load results from the National Laboratory 




1.6.3 How is the EHR implemented and used in Malawi? 
The EHR in Malawi was designed to be used at the point of care, meaning that a workstation is 
present at each location that a patient interacts with a health care provider. The EHR uses a touch 
screen input enabled computer system, similar to that of a point-of-sale device used in 
supermarkets. The system follows a wizard-like design to simplify navigation of guideline 
recommendations through the system. Figure 1.4 presents the use of an example of the clinical 
workstation (59). The points of care at a health facility are mapped to the patient flow with figure 
1.5, representing an example of a typical workflow and various points of care where an EHR 
would be deployed in an ART clinic.  
 
Figure 1.4 Clinical Workstation Touchscreen 
 
Figure 1.5 Typical ART Clinic Points of Care and 
Workflow 
In deploying the EHR, different stakeholders, directly and indirectly, interact with it. A 
stakeholder is broadly defined as a person with an interest or concern in something (60). In this 
study, I defined stakeholders as anyone with interest with the EHR in Malawi either by direct use 
or indirect use of its data, including organizations that fund the implementation of the EHR. I did 
not include patients as part of this study due to scope and feasibility issues.  I present a 
comprehensive list of stakeholders in Table 1.3. I also show possible data uses of the stakeholder 
groups with examples from the ART clinic in the same Table. These stakeholders were targeted 







Table 1.3 Stakeholder group roles and their functions 
Stakeholder 
role 
Point of Care Privileges/Use of 
Documented encounter 
Example of DQ Challenge 
Clerk Reception Registration of patients for 
patient identification. 
Generating reports. 
Documenting vital signs 
The same patient may have 
multiple IDs. 
Nurse Nurse room All of the clerk + patient 
assessment such as adherence 
to medication; dispensing of 
prescription; referral to the 
clinician. 
Out of range or missing, weight 
and height observations may 
affect programs that result in 
referral of patients for 
therapeutic feeding. 
Clinician Clinician room All of the nurse + initial patient 
assessment (HIV stage 
defining conditions); 
prescription; diagnostic 
requests; treatment plan. 
Wrong prescription identified by 






Generate reports; Assess 
outlier patient cases, e.g., 
patients that changed from 2nd 
line treatment to first-line 
treatment. 






Review reports; interpret 
aggregate data for drug 
redistribution such as a number 
of patients alive and on 
treatment. 
High numbers of patients 
flagged as defaulters/lost to care 
may result in under or over 






Access EHR data in response 
to specific research questions 
that they may have. 
Interpretability of the data. 
Donor groups Donor 
organizations 
within the country 
Use EHR reports for their 
specific program goals and 
objectives. 
The flexibility of reporting and 





As the data in Table 1.3 suggest, different stakeholders have different documentation needs. 
1.7 Defining Data Quality 
Data quality is usually defined according to different characteristics (61), which lead to different 
definitions. Some of the frameworks in the literature include the ISO data quality framework 
(62), the Kahn et al., harmonized framework of secondary data use (63), the consumer network 
framework of defining data quality (64). Weiskopf et al. (65), also established a framework for 
defining electronic data quality, and lastly, the WHO (66) also has a framework for defining data 
quality. All of these frameworks have specific data quality characteristics that they use in 
describing data quality. In a LIC setting such as that of my study, the WHO framework is 
important because most health programs in LICs adopt WHO guidelines. I, however, observed 
that the WHO framework focuses on aggregate data alone (66) while my interest in this study is 
on patient-level data. Thus, I did not use the WHO data quality framework for my study. 
The other frameworks listed above describe data quality with different terminologies as 
characteristics of data quality. For example, the ISO framework describes data quality using 15 
data quality dimensions. These data-quality dimensions are split across two main categories of 
inherent data quality characteristics and system-dependent data quality characteristics (62). The 
consumer network data quality framework also groups data quality dimensions into main 
categories. Two categories are similar to the ISO framework in that they define intrinsic data 
quality characteristics, just like the inherent data quality characteristics in the ISO framework. 
The other category is similar to system-dependent data quality characteristics but describes them 
as contextual data quality characteristics. The consumer network data quality framework 
continues with two additional categories for data quality, namely representational and 
accessibility data quality characteristics (64). Weiskopf et al.(65) in their discussion of electronic 
data quality, described data quality using an earlier review on the most used data quality 
characteristics for EHRs. They found that completeness was the most used dimension for data 
quality in EHRs. Like the other previous two frameworks, they also brought into discussion data 
quality as being intrinsic or extrinsic, the former defining the data quality of selected variables 
and the latter describing any factors influencing the observed individual data quality. Another 
aspect when thinking of data quality in terms of the Kahn framework is the idea of verified data 





characteristics are achieved with reference to a single dataset (63). In the case of my study this 
would be focusing on EHR data records in ART clinics for HIV/AIDS only. Validation is 
another step of data quality assessment where data quality is assessed with an external data 
source (63). In the case of my study, I would need to get additional data sources that may be used 
as a benchmark of observed data had I focused on validation.  
My observation was that there is an overlap in terminology across these data quality frameworks. 
I selected the Kahn harmonized data quality framework, which assessed several data quality 
frameworks, including some of the ones mentioned above because it is the most recent 
framework of data quality, and it has harmonized terminology from most of the frameworks 
reviewed above (63). 
1.7.1 The Kahn Harmonized Data Quality Terminology Framework 
To achieve consistency in the definition of data quality in the context of EHR, Kahn et al. 
introduced a data quality framework for secondary data use (63). This work was motivated by 
the multiplicity of frameworks and definitions regarding data quality and lack of consistent 
terminology, which presents barriers to comparing data quality across different settings. To 
address these issues, they harmonized the critical data quality dimensions or characteristics, 
mapping them to the dimensions of completeness, conformance, and plausibility.  
Completeness means having a value that fully represents observations that occurred as expected. 
Conformance, on the other hand, refers to observed values following the prescribed format. And 
lastly, plausibility is more concerned with the credibility of observed values in terms of range 
and external validity. For example, having a male patient with pregnancy observation would not 
be plausible (63).  
The Kahn framework gives examples of secondary data use as quality improvement initiatives 
and research purposes, usually in large research settings. Therefore, the Kahn framework for 
secondary data use would be appropriate in thinking about data quality in the context of my 
study. Although public health reporting motivated the EHRs in Malawi, the country adopted a 
transactional system where health care providers use the EHRs at the point of care (15,21). This 
adoption of transactional systems is in contrast to other regions in LICs where reporting systems 
have been adopted. The first example maps to the transactional use of the EHR in Malawi, where 





quality improvement through enforcing adherence to best practice in managing patients through 
the HIV care process. 
Therefore, in the case of Malawi, there is the primary use of the data, and the secondary data 
uses come in as a by-product of the primary data collection by the healthcare providers.  
The challenge of data quality in Malawi has been echoed in the implementation of EHRs in other 
countries that have deployed EHRs in ART clinics for HIV too. For example, a study at a high-
volume clinic in South Africa pointed out accuracy as a challenge in documented clinical 
encounters (67). Accuracy is harmonized with plausibility in the Kahn framework when assessed 
with previous frameworks whose terminology have been mapped to the proposed terminology of 
the Kahn data quality framework. 
Different stakeholders perform different documentation tasks giving them different end goals. 
This variation in goals implies the need of further understanding of the context of any observed 
data quality. The characteristics harmonized by the Kahn framework are firstly intrinsic to the 
data (40). A study that used the Kahn framework in six data sharing networks to conduct a data 
quality assessment recognized the shortfall of focusing on intrinsic data quality alone and 
adopted the view that data quality should be fit for purpose (40). In this study different data 
quality characteristics were attached to different stakeholders in order to understand the context 
of their data quality assessment (40). The Kahn framework also states the need to adopt this view 
of data quality “being fit for purpose” (63).  
The definition that data quality is “fit for purpose” recognizes that different stakeholders who use 
EHR data will have different purposes of data use. For example, in the case of audit and 
feedback to improve adherence to clinical practice guidelines, the expectation is that data should 
be complete and accurate for these purposes (38). In the case of audit and feedback, if a 
performance measure on prescribing the right drug is to be calculated, healthcare providers may 
need to know several aspects of a patient’s health before prescribing a drug. One piece of 
important information to a clinician may be whether a patient is allergic to sulfa, which would 
prevent the prescription of sulfa drugs. On the other hand, public health officials may only be 
interested in knowing what prescriptions have been dispensed, which would be important in 
deciding which drugs to order.  
In the case of Malawi, there are public stakeholders who use secondary data for purposes such as 





healthcare providers such as nurses and clinicians have primary purposes of data use from the 
EHR on direct patient care decisions that are dependent on collected EHR data such as the drug 
regimen that a patient is on and the quantity that was dispensed. This data would be useful for 
calculating patient adherence to taking their drugs according to the prescribed dosages. With 
reported EHR data quality challenges, I therefore used the view of data quality being fit for 
purpose to explore EHR data quality in ART clinics in Malawi. 
1.7.2 Understanding Malawi EHR Data Quality “fit for purpose”  
Data quality remains a problem in ART clinics using EHRs in Malawi (50). There have also not 
been studies that have reported any new approaches to understanding data quality beyond the 
intrinsic data quality in this setting. I believe this approach does not provide a comprehensive 
understanding of data quality. Additionally, with the reported poor data quality in Malawi, any 
interventions to improve data quality that would not take purposes of data use into the context of 
data quality assessment would fall short of improving data quality. Purposes of electronic data use 
have been recognized by the WHO in a classification of digital health interventions that have been 
rolled out in LMICs for different stakeholder groups (67). These role functions have not been 
confirmed as purposes of data use in the context of data quality assessment. I therefore used this 
study to identify relevant and significant purposes of data use in ART clinics in Malawi with 
reference to the electronic data purposes of use in the WHO classification of digital health 
interventions. Given the absence of a systematic assessment of ART data quality in ART clinics 
for HIV in Malawi, one that takes into consideration purposes of data use of stakeholders, I asked 
the question below, with consideration that stakeholders continue to report poor EHR data quality:  
How do stakeholders’ varying purposes of EHR data use inform interventions for EHR data 
quality improvement?  
AIMS 
The aims of my research were conducted within the context of the 90-90-90 efforts of 
eradicating HIV/AIDS in Malawi by 2030: 
1. To identify the importance of data quality characteristics in the context of EHR 
stakeholders’ purposes of data use. 
a. To identify purposes of data use for different stakeholders using 
the EHR data. 
b. To identify characteristics of data quality that stakeholders using 





c. To rank the importance of data quality characteristics in 
accordance with purposes of data use across different stakeholders 
using the EHR data. 
2. To conduct a “fit for purpose” data quality assessment and evaluate the drivers of 
the observed data quality.  
a. To conduct a data quality assessment of EHR data based on Kahn 
framework data quality characteristics and purposes of use in ART 






















Chapter 2 Research Methods 
2.1 Chapter Overview 
In this chapter, I present methods for the research question and aims presented at the end of 
chapter 1 and restated below: 
1. To identify the importance of data quality characteristics in the context of EHR stakeholders’ 
purposes of data use. 
a. To identify purposes of data use for different stakeholders using the EHR and 
EHR data. 
b. To identify characteristics of data quality that stakeholders using the EHR and 
EHR data expect. 
c. To rank the importance of data quality characteristics by purposes of data use 
across different stakeholders using the EHR and EHR data. 
2. To conduct a data quality assessment and evaluate the drivers of the observed data quality.  
a. To perform a data quality assessment of EHR data based on Kahn framework 
data quality characteristics and purposes of use in ART clinics in Malawi 
 
I conducted a mixed methods study to address the aims above. I present the methods for each 
aim with its sub-aims, starting with the study population, sampling, data collection, and the data 
analysis approaches. The aims above link to key documents and frameworks, introduced at the 
end of Chapter 1, including: the Kahn data quality framework, the WHO Classification of Digital 
Health Interventions, and a practical application for assessing data quality, namely the 90-90-90 
targets for HIV/AIDS eradication. I mapped these documents to inform the studies I conducted 






Figure 2.1: Schematic of mapping research methods and study results for Studies 1 and 2 
I discuss the detailed research methods represented in Figure 2.1 in sections 2.6.1 and 2.6.2. for 
study 1, and in section 2.6.3 for study 2. The results are detailed in chapter 3. I illustrate the 
linkages of the different documents and frameworks for study 3 in Figure 2.2.  
 
 
Figure 2.2: Schematic for research methods and results for study 3 






2.2 Overview of Methods  
I used mixed methods with the belief that measuring data quality using quantitative methods 
alone would be insufficient because it would miss other factors that may influence data quality. 
These factors could be different purposes of data use by stakeholders selected in this study. For 
instance, in a review by Hong et al., they observed that quantitative data quality assessment alone 
was insufficient as other factors may explain observed data quality after conducting a qualitative 
assessment. Many studies followed up the quantitative studies with qualitative research to 
understand or explain the results of the quantitative data quality assessment (61). 
I purposively selected health facilities at three different levels of care for all the aims to achieve 
site representativeness. I selected the list of health facilities from a list of health facilities that use 
the EHR. After I purposively selected a list of health facilities in each health zone, I shared it 
with the EHR implementer, Baobab Health Trust, and the MoH to get their approval.  
Healthcare levels vary in terms of infrastructure and resources such as human capacity as well as 
the approved medication list and services rendered (54). The sites were purposively selected to 
meet geographical and health level representation.   
Data collected at different healthcare levels may differ in data quality due to these resource 
differences. I made this distinction based on data quality studies similar to mine, where they 
made site selections based on different health facility levels and resources (37). I used the target 
site population in Table 2.1 below to address both Aims 1 and 2. 
 
Table 2.1: Target Health facilities with EHR for Aims 1 and 2 
Health Zone Health Facility Type Health Facility Health Level 
South East District Hospital Mangochi District Hospital Secondary  
 Central Hospital Zomba Central Hospital Tertiary 
South West Health Center Limbe Health Centre Primary 
 Central Hospital Queen Elizabeth Central 
Hospital 
Tertiary 
Central West District Hospital Salima District Hospital Secondary 





 District Hospital Dedza District Hospital Secondary 
 Central Hospital Lighthouse Hospital Tertiary 
Northern Health Center Mzuzu Health Center Primary 
 District Hospital Nkhatabay District Hospital Secondary 
 Central Hospital Mzuzu Central Hospital Tertiary 
 
2.3 Research design 
This research was an observational study design using mixed methods to address my research 
aims. I followed a guideline titled “Reporting mixed research in the field of counselling” from 
Enhancing the Quality and Transparency of Health Research (EQUATOR) web site (68,69). The 
guideline recommends that researchers should choose a framework which guides their research 
design (70).  
 I collected retrospective quantitative data for the period of January 1st, 2017 to December 31st, 
2018. I targeted this period based on an assumption that there would not be significant changes 
in the EHR data since the most recent guideline that was in use was implemented in 2016. My 
study followed a convergent framework for conducting a mixed-methods study design (69,71). A 
schematic adapted from Steinmetz-Wood et al. (69) illustrates the method I followed in doing 


















– Aim 1 
Template 
analysis to 
identify themes Interpretation – 
integrate key themes, 
theme categories with 
proportions, charts in 
relation to study  aims 




– Aim 2 





2.4 Mixed Method Study Design Integration Approach 
Theme by statistics or theme side by side comparisons are two ways of displaying the integration 
of convergent mixed study results (72). I used side by side theme comparison for Aim 1 and 
theme by statistics for integrating Aims 1 and 2. Side by side theme comparison presents 
qualitative themes for each objective side by side in a table, whilst theme by statistics adds 
quantitative results to the qualitative themes identified. Figure 2.4, adapted from Wood et al. 












I presented the integration of both Aims 1 and Aim 2 using tables which were a buildup of the 
findings under each aim.  
 
 Comparison 
AIM 1 vs AIM 2 
Comparison of 
interdependent data 
aims 1a,1b and 1c 
Comparison from 
interviews (aims 1a, 1b 
& 2) and quantitative 
analysis 
Comparison of diverging 
findings – within aims 
and across aims 





2.5 Overview of Study Measures 
Measurement is the process of assigning a value corresponding to the presence, absence, or 
degree of a specific attribute in a specific object (73). I considered the purposes of data use as an 
object with the WHO digital classification of digital health interventions as attributes for my first 
study. Additionally, I measured data quality as an object with the data quality characteristics as 
the attributes for my second and third studies. Measurement requires defining or using existing 
instruments to ensure that the attribute of the objects that are intended for measurement are 
precisely captured. In the case of my study, I used instruments defined by the researcher and 
informed by experts and other existing frameworks. The expertise for validating the researcher 
defined instruments such as interview guides was provided by my research committee. 
Additionally, I used the Malawi HIV/AIDS treatment guideline recommendations to define 
database queries for responding to Aim 2. I present my measurement approaches in Table 2.2 
below. 
 
Table 2.2 Summary of Measurement Approaches for Study Aims 





Measures of variables, or 


















Purposes of data use 
- Stakeholders’ 
EHR data use.  
 Researcher defined Semi 
Structured interview guide 
 
- Open ended 
questions: Do you 
use data in your 
job? 
- What/how do you 











      
1b 34 
participants:  
10 Nurses  
5 Clinicians 
Anticipated stakeholder 
data quality characteristics  
- Data quality 
dimensions/chara
 Researcher defined Semi 
structured interview guide 
 























expected in the 
data accessed. 
- What data quality 
characteristics do 
you anticipate 
when using data for 
your job? 
- Of the data quality 
characteristics, 























priority levels for data 
quality characteristics 
 







purposes of data 
use in the context 





 Researcher designed 
questionnaire. 
Importance priority levels of 
data quality characteristics 
across selected 90-90-90 
purposes of data use. 
(Patient identification; 
Patient retention; Patient 
HIV viral load monitoring) 
 

















data use and 










      



















absence of data 
values regardless 
of the structure 
















Body Height  
Database queries using3 
MySQL and later counts of 
numerator and denominators 
for different data quality 
characteristics based on the 
Kahn Framework for each 
data quality characteristic 













2 These 11 participants for Aim 1c, were a subset of the 34 participants from Aims 1a and 1b. 
3 Queries and measures checked for external and internal validity with Software Development Manager at Baobab 
Health Trust, the implementer of the EHR. The measures were also checked by the Director of Monitoring and 























value in terms of 


















load results for 




Completeness = Total 
Number of Records with a 
recorded value / Total 
number of records in line 
with that variable. 
 
Plausibility: Measured 
Temporal Plausibility and 
Atemporal Plausibility 
Temporal plausibility = 
Total number of records 
falling after a patient is 
enrolled in the ART clinic / 
All records within the study 
period for that particular 
variable. 
 
Atemporal plausibility = 
Total number of records that 
meet the range definitions 
according to the Malawi 
treatment guidelines for 
HIV/AIDS or reference 
tables /   All records within 











2.6.1 Aim 1 Study Sample 
The target sample included stakeholders such as healthcare providers, public health officials in 
the MoH, and selected donors of EHR investments in the country. I used this target sample for 
all sub aims under Aim 1 since I felt this target sample would identify individuals with different 
data needs based on the key stakeholders presented in Table 2.3. Healthcare providers were 
targeted due to their interaction with the EHR at the point of care while offering various services 
in the ART clinics for HIV. Their interaction with the EHR as a tool for documenting the 
services they provide to patients prompted me to target them since I believed have probably 
experienced effects of poor data quality on their use of the EHR. I targeted other stakeholders 
because they use by-products of the point of care data collection in their day-to-day activities. 
These activities may be the design of public health interventions and the procurement of 
commodities such as drugs. I present the stakeholders targeted in this study in Table 2.3 below: 
 
Table 2.3 Health Area and Stakeholders Targeted for Interviews 
Health Area Stakeholders Sample  
Patient care Health facility healthcare providers (nurses, 
clinicians) 
Data services (Data clerks, Health 
management information systems officers) 
The target population of: 
27 based on health facilities in 
selected health zones at different 
health levels. 
Supervisory Staff MoH Supervision team or Health Facility 
managers in Zonal offices 
Target population of:  
5 based on the total number of 
health zones in the country. 
Donor representatives Project officers of Donor funding agencies 
that fund organizations that implement the 
EHR.  
Target population of: 
3 based on the main donors of 
EHR investments in the country. 
Public Health Policy Program/section directors; National 
Monitoring and Evaluation (M & E) 
coordinator; Drafters of Clinical Practice 
Guidelines; 
Target population: 2 based on the 
MoH officials that directly use the 






2.6. 2 Methods: AIM 1a and AIM 1b 
2.6.2.1 Sampling: AIM 1a and AIM 1b 
I used purposive sampling to select the study participants for Aim 1 based on the criteria that 
stakeholders use the EHR and the EHR data either at ART clinics while seeing patients or in 
other capacities such as donor programs or HIV/AIDS public health needs. Since this was a 
convenience sample, the results would only be applicable to similar group of participants. 
Site sampling 
To take into consideration the site representativeness of responses of healthcare providers, I 
interviewed participants from different healthcare levels, such as primary, secondary, and tertiary 
healthcare levels. These healthcare levels attend to different patient catchment populations, 
increasing across each level, as stated in section 2.2 above (54). Other stakeholders were in 
central monitoring offices either for the MoH, EHR donor organizations and zonal public health 
offices.  
Study participant stakeholders 
Study participants for Aim 1 were also purposively selected based on their direct and indirect 
interaction with the EHR in their capacities as healthcare providers, data service providers and 
management services, supervisors, donor representatives and public health policy officials of the 
EHR implementation in the country.  
Health care providers and data services 
Each health facility has roles of healthcare providers such as data entry clerks, data officers, 
nurses, and clinical officers (74), medical assistants, and medical doctors.  
Clinical officers or clinicians are trained to perform general medical and surgical procedures 
such as cesarean sections and are required to complete an internship program before they may 
start practicing. Nurses may also become clinical officers, but only in the specialty that they train 
in. For example, if they train in anesthesia, then they are referred as clinical officers only in that 
area unlike the general training of clinical officers. These cadres exist in Malawi to fill the gap of 
the low number of medical doctors (74). 
Medical assistants get only two years of clinical medicine training and are not required to fulfill 





I used purposive sampling to select at least one of these roles for Aims 1a and 1b. Specifically, I 
attempted to have at least 2 participants from each role so that I could validate individual 
responses. After interviewing the first study participant in these roles, I used snowballing 
techniques to identify additional stakeholders in the health areas of patient care and data services 
(75). At the health facilities, I asked for a name of an individual to interview next based on a role 
that I had not interviewed yet at that facility. So, for example, if I had already interviewed a 




Supervisory staff at the health facilities were healthcare providers who lead different care and 
administrative activities. These were the point of contact at each health facility. I selected the 
first participant for an interview with the guidance of the clinic manager with whom I met to give 
an overview of my study and get permission to conduct interviews.  
Public health officials and Donor representatives 
For other stakeholders such as public health officials working in government offices and non-
profit organizations that also use the EHR, I made a list of potential interviewees and contacted 
them to set up the interviews. I compiled the list of stakeholders after meeting one key EHR 
stakeholder at a center of excellence for HIV/AIDS treatment. I selected this individual based on 
his key role in using EHR HIV/AIDS data at the HIV/AIDS treatment center of excellence. He 
then made suggestions of names of people to be considered for interviews. I then sent e-mails to 
this list of stakeholders to book an appointment for an interview. Afterwards, I conducted 
interviews with the stakeholders that had responded to be interviewed, whilst following up on 
those that had not responded yet. To identify additional stakeholders in this stakeholder group, I 
asked the interviewee to recommend other possible participants. 
I identified donor representatives of the EHR by first discussing with the implementer of the 
EHR on who their active donor funding agencies were. I then scheduled meetings with the donor 
representatives to conduct my interviews. 
2.6.2.2 Data Collection Aims 1a and 1b 
I used the semi-structured interview guide in Appendix 1 to address Aims 1a and 1b. I developed 





data and anticipated data quality characteristics (63,67). To ensure further validity of my data 
collection tool, an expert in my research committee reviewed the questions for Aims 1a and 1b.  
I interviewed study participants at their workplace, in a room with the door closed or a quiet 
open space away from other individuals where a private room was not available. I recorded the 
interviews on a voice recorder after reading out the overview of the study to the study 
participants as part of seeking informed consent. Interviewees signed informed consent 
documents as evidence of their consent. 
2.6.2.3 Data Analysis: AIMS 1a and 1b 
Since this was an observational study design using mixed methods for data collection and 
analysis, I conducted a thematic analysis to identify common themes on purposes of data use and 
the data quality characteristics that they anticipated in the data for Aim 1. I followed the steps 
below for the qualitative data analysis: 
Thematic Analysis Steps 
1) Coding: I first gained familiarity with the data through transcribing the interviews. After 
gaining familiarity with the data, I conducted a template analysis based on the World 
Health Organization (WHO) classification of digital health interventions (CDHI) and the 
Kahn data quality framework for secondary data use and (63,67). I did this for Aims 1a 
and 1b respectively. The WHO CDHI is a list of digital health interventions mapped to 
broad areas of stakeholder groups and their purposes of use. After transcribing, I searched 
for words or phrases that were closest to the defined codes and mapped them to the codes 
in NVivo(76) for both Aims 1a and 1b. I have included the codebooks used for this stage 
as appendices 2B and 2C. I used the qualitative data management analysis software 
NVivo(76) to manage the data by importing the transcribed interviews, defining a 
codebook in the software, and then assigning the responses of the interviews to relevant 
codes in my codebook. I used the WHO CDHI to develop a codebook for defining 
purposes of data use.  
2) Identifying themes: Keeping the research question in mind, I continued to identify 
emerging themes from the data. The emerging themes were explored by identifying 
phrases that linked to specific codes.  
3) Recoding: I then reviewed the transcripts to assess for the presence new codes.  I 





objectivity to the coding, I took breaks of up to two weeks before starting to recode the 
transcripts so that I bracketed myself from the earlier coding that I performed (75).  
4) Theme significance: I ranked the themes based on emphasis and frequency of repetition 
of emerging concepts in the themes (75,77). Additionally, I validated the important 
themes with the WHO CDHI (67) in the case of purposes of data use. I used the Kahn 
harmonized data quality framework for secondary data use (63) to code expected data 
quality characteristics. The WHO CDHI is the most recent publication on digital health 
interventions mapped to stakeholder purposes of data use. The Kahn framework 
harmonizes data quality characteristics from many other frameworks and therefore was 
relevant for my coding approach. 
5) Report writing. I then produced a report based on the themes that I identified. 






Table 2.4 Thematic Analysis Table 





Re-listen audios Final transcripts 
Type and translate any 
audio interviews  
 
 
Coding by Objective 
Initial codes by data 
use and stakeholder 
group classification 
Secondary coding 
Final codes by data 
use and stakeholder 
group classification 
from the WHO CDHI 
To establish the ways 
that data are used or 
would like to be used by 
different stakeholders 
working to manage 
HIV/AIDS patients and 
are using or expect to 
use an EHR 
 
To identify 
characteristics of data 
quality that would help 
stakeholders determine 
whether the data are fit 
for their purpose/fit for 
their intended use of the 
data. 
 
Initial codes by data 
use and cadre 
Secondary coding 
Final codes by data 
use and stakeholder 
group classification 
mapped to the Kahn 
Data Quality 
Framework 
To determine the relative 
importance of the 
characteristics of data 
quality characteristics 
expected based on the 
Kahn framework. 
Initial codes by data 
use and cadre 
Secondary coding Final codes by data 
use and stakeholder 
group importance 
from the Kahn Data 
Quality Framework. 
    
Emerging Themes 
Initial themes per code 
Theme significance Final codes: 
1) Purposes of 
data use  
mapped to the 
WHO CHDI 
2) Expected data 
quality 
characteristics 
mapped to the 
How do purposes of 
EHR data use of 
stakeholders inform 























2.6.3 Methods: Aim 1c 
2.6.3.1 Study population Aim 1c 
I targeted a subset of the stakeholders from Aims 1a and b for this Aim. I used convenience 
sampling to select the participants for AIM 1c based on who was readily available. I identified 
the participants from the same list of participants as Aims 1a and 1b. The number of participants 
for this Aim were guided by geographical access and the representation of stakeholder types. To 
understand the relative importance of data quality characteristics, I used an interviewer-
administered questionnaire provided in Appendix 4. I asked stakeholders to rank the importance 
of data quality characteristics concerning selected data uses mapped to the 90-90-90 HIV 
eradication strategy. The selected purposes of use were further mapped to examples of digital 
health data uses as classified in the WHO CDHI. This was done to enable integration between 
anticipated purposes of data use from stakeholders and practical use of these purposes with the 
example of the 90-90-90. The 90-90-90 HIV eradication strategy was chosen because they are an 
essential global strategy that has been adopted by Malawi (58).  
 2.6.3.2 Sampling Aim 1c 
Public health officials such as zonal quality control managers, donors, national monitoring and 
evaluation experts as well as healthcare providers at ART clinics from the northern zone were 
selected for this Aim. I chose the participants as a continuation of the interview process for Aims 
1a, and 1b. After completing questions for Aims 1a and b, I would proceed to ask questions for 
Aim 1c. I administered the questionnaire to the study participants and recorded the responses 
they gave me. I interviewed 11 participants only for this Aim 1c because the interview 
questionnaire was not ready at the time the participants of Aims 1a and 1b were being 
interviewed. I thus could only feasibly access the 11 participants that were conveniently located 
to participate in Aim 1c.  
2.6.3.3 Data Collection Aim 1c 
I used data quality characteristics harmonized in the Kahn data quality framework for secondary 
data (63). The data quality characteristics that were ranked are conformance, completeness and 
plausibility. I mapped these data quality characteristics along with purposes of data use as 
classified by the WHO (67). Table 2.5 below presents how I mapped the WHO classification of 







Table 2.5 WHO Data Uses Mapped to 90-90-90 Goals 
90-90-90 Example Requirement 
from EHR 
WHO CDHI data use 
mapping 
Question for establishing the 
importance of characteristics. 
Identification of HIV positive 
patients 
 
The first 90 is a goal to identify all 
people that are HIV positive and get 
them enrolled in care. This may be 
possible with unique patient 
identifiers and other patient 
demographic information. 
Supply chain management 
(Patient identifier will help in 
calculating number of patients 
to receive drugs) 
Location mapping (Patient 
identifier will help in 




Given unique patient identification, 
which is an example of client health 
records data use, compare importance of 
the two characteristics below (pairwise 
comparison of completeness, 
plausibility and conformance) 
Client health records (Patient 
identifier is used to pull 
individual patient records) 
 
Retention into care with adherence 
to Clinical Practice Guideline 




Once patients are enrolled in care, 
the appropriate care should be given 
to patients by following clinical 
practice guideline recommendations. 
This recommendation is dependent 
on transactional data at the point of 
care. It may also be dependent on the 
availability of essential commodities 
such as the actual medications. 
Healthcare provider decision 
support (Thresholds of BMI 
or Adherence trigger decision 
support to healthcare 
providers) 
 
Given patient retention into care which 
may have applications towards 
healthcare provider decision support, 
prescription and medication 
management and healthcare provider 
communication compare the importance 
of the two characteristics below 
(pairwise comparison of completeness, 
plausibility and conformance) 
 
Prescription and medication 
management (Dosing 





(Data entered at one point of 
care available for use at 
another) 
Viral load suppression at required 
milestones 
 
To prevent transmission to other 
people, HIV positive people need to 
achieve non-detection of their viral 
load. This goal requires viral load 
monitoring at the correct milestones 
so that 90% of the population 
reaches the viral load suppression. 
Laboratory and diagnostics 
imaging management (Viral 
load results saved in the ART 
EHR) 
 
Given viral load suppression which is 
an example of laboratory and diagnostic 
imaging data use, compare the 
importance of the two characteristics 
below: (Pairwise comparison of 









I used the purposes of EHR data use above as examples in mapping the importance of data 
quality characteristics across selected stakeholders. I have included the interviewer-administered 
questionnaire for this Aim, as Appendix 4.  
I interviewed study participants using the data collection tool in Appendix 4 and entered the 
responses on a paper questionnaire. I later entered the interviewees’ responses onto an online 
form designed using Google forms. I used a paired psychometric method (78) when 
administering the questionnaire to deal with the challenges of extreme response syndrome when 
respondents may reply to every characteristic as being very important or not important at all. In 
this approach, I asked participants to compare the importance of data quality characteristics 
relative to one another.  
2.5.3.4 Data Analysis Aim 1c 
I used frequency tables to count the number of times a data quality characteristic was ranked 
higher in importance compared to another data quality characteristic for a given purpose of use.  
I calculated the number of possible pairwise comparison combinations of data quality 
characteristics for a selected purpose of data use with the formula below (78): 
!"##$%&'	)*+%',	"-	!.$,/$#'	0"+%$).1$")# = 30(0 − 1)2 9	
The letter “c” denotes the total number of candidates or options that may be chosen from. Data 
quality characteristics were the candidates in the case of my study. Therefore, the possible 
combinations for comparison were: 
(3(3-1)/2) = 3 
I asked stakeholders to rank importance of the data quality characteristics of plausibility, 
completeness and conformance across 3 selected purposes of data use from the 90-90-90 that I 
mapped to the WHO CDHI. The 3 possible pairwise of data quality characteristics comparisons 
were: 
Plausibility vs Completeness 
Plausibility vs Conformance 
Conformance vs Completeness 
I asked stakeholders to rank the highest level of importance between the data quality pairs above 
for a purpose of data use, for example viral load monitoring data use, in order to determine a data 





each data quality characteristic with an example for them to understand the data quality 
characteristic. 
For each purpose of use, I assigned a score of 1 for each data quality characteristic of the pair 
that was ranked higher, and 0 for each characteristic that was ranked lower in each pair. I 
assigned 0.5 of a point in the event that stakeholders attached the same importance to a pair of 
data quality characteristic for a selected purpose of data use (79). I then, summed total votes for 
each characteristic across all participants for each purpose of use.  Table 2.6 below shows how I 
assigned the votes. 
 















Purpose of use example: Unique patient identification 
Plausibility             
Completeness             
Plausibility             
Conformance             
Conformance             
Completeness             
 
I then arrived at the importance for a given data quality characteristic by comparing the sum of 
data votes across the different data quality pairwise comparisons. The data quality characteristic 
with the most votes had the highest priority. This process was repeated across the different 






2.6.4 Methods: Aim 2a 
2.6.4.1 Study Population: Aim 2a 
For the quantitative part of this study, adult patient EHRs were the target population. Adults are 
defined as all patients above 14 years of age by the Malawi MoH (54,80). I again selected the 
variables on which to perform a data quality assessment concerning the HIV/AIDS eradication 
goals stated in earlier sections (81). My decision to select variables was informed by identifying 
variables that are useful to meet the strategic goal of the 90-90-90 targets for HIV/AIDS 
eradication. I targeted the variables below from the EHR as per Table 2.7 below: 
Table 2.7 90-90-90 Goals and EHR Variables selected for the study. 
90-90-90 data use Variable 
Patient tracing Patient Physical Address – the current place of residence 
Patient phone number – mobile phone number for patients. 
Quality of patient care Prescribed and dispensed drugs 
Quantity of ARV drugs and Cotrimoxazole Prophylactic Therapy 
(CPT) drugs dispensed to patients 
 
Patients' drug adherence – The presence of adherence calculations and 
whether they are within range. 
 Body mass index – weight and height observations. 
Viral load suppression Viral load results present as a proxy for viral load orders.  
Date viral measured in comparison to starting of the Viral load 
program. 
Interval of viral load testing.  
 
The data uses above represent examples of data that are collected electronically and are directly 
used to respond to the HIV 2nd and 3rd program goal of eradicating HIV by 2030 (90-90-90) by 
achieving these targets by 2020(58). I selected the patient variables that facilitate patient tracing 
because they ensured that patients remained on treatment in the event that they missed their 
hospital appointments and would need to be followed up at their homes using their address or 
phone number. I further selected some variables that may be associated with the quality of care 
that patients receive at hospitals, such as the drugs prescribed or continuous monitoring of vital 





program. The last variable of viral load results would enable monitoring of the viral load, hence 
the I selected this as well. 
2.6.4.2 Sampling: Aim 2a 
Patient study population 
I purposively sampled adult patient (older than 14 years) records of HIV positive patients at 3 
different healthcare levels in the country so that there is site representation. Adults are all 
patients that are above 14 years in the Malawi health system (80). These were patient records of 
all patients that were alive during the study period. I did not exclude records of patients who died 
during the study period.  In addition to the healthcare level, the health zone (54,82), in which the 
health facility falls, was also taken into consideration when selecting the health facilities. 
Site sampling 
I selected all health facilities targeted in this study as presented in Table 2.1. At the time of this 
study, the EHR had been deployed in about 193 health facilities out of over 700 health facilities 
in the country (83). Although this represented site coverage of only 28%, these were mainly 
high-volume ART health facilities, and they cumulatively managed over 50% (~370,000) of all 
patients alive and on treatment in the country (~780,000) (50). I used purposive site sampling to 
select health facilities for this study. I selected at one health facility at each health level in each 
of the 5 health zones in Malawi.  
Since the patient records at the health facilities are in electronic format, I selected all records that 
fell between January 2017 to December 2018. I chose this period because I believed that there 
had not been any significant changes with the EHR system within my research period with 
regards to clinical practice guideline recommendations (80). I found that there were some 
changes that happened to the EHR during the period when I was conducting my electronic data 
collection. Specifically, I found that the EHR viral load order record function was not updated in 
the EHR. Additionally, I found that the viral load results were available in only three of my 10 
target health facilities. To address the first change, I opted to use viral load results as a proxy for 
assessing the data quality of viral load order requests. Secondly, I modified my site population to 
target the three health facilities that had viral load results data. These three health facilities were 
Queen Elizabeth Central Hospital, Zomba Central Hospital and the Lighthouse Trust at the 





2.6.2.3 Data Collection: Aim 2a 
Variables were collected in line with the 90-90-90 targets for data quality assessment in line with 
the Kahn data quality characteristics of completeness and plausibility. I did not focus on 
conformance because the process of achieving this measure was beyond the scope of my work as 
I would need to do more preliminary work to understand the database structure of the EHR. I 
have summarized these variables in Table 2.7 of this chapter. I dropped the unique patient 
identifier for the first 90 because I discovered that this variable was in a new EHR module that 
was not available in most of the targeted health facilities, hence the data not being available. The 
first 90 has also been observed as a challenge to measure at the national scale (51). The three 
health facility data that I used for the final 90 assessment were central hospitals that maintained 
the same organization and were complete. 
I used the MySQL database management system in writing the database queries to extract these 
data and exported the data to a comma-separated value (CSV) format (84). Two developers from 
Baobab Health Trust, the organization that designed and implemented the EHR in Malawi, 
checked and edited as necessary, and ran queries on the site databases (85). They provided me 
with the anonymized datasets by uploading them to a secure Dropbox drive. I then transferred 
these datasets to a secure drive. Some datasets were corrupted with transposed column values 
and required regenerating. After I reported this to the developers, they generated the new datasets 
and re-uploaded them. Again, I immediately transferred the datasets to a secure Box location for 
further data analysis.  
2.6.4.4 Data Analysis: Aim 2a 
I used the Kahn harmonized data quality framework for secondary data use to operationalize the 
definitions for my data quality assessment in relation to the 90-90-90 HIV eradication targets. 
The Kahn framework helped to come up with broad classes of definitions for data quality. I then 
made the data quality definitions more specific by selecting variables that map to the 90-90-90 
targets for HIV eradication, which have been adopted in Malawi (58). The variables were 
selected after confirmation that they were being collected in the EHR. I followed up on the 
variables in Table 2.7 with the EHR implementer to confirm that the data were indeed collected.  
Initially, I planned to conduct the data quality dimensions assessments based on validation and 
verification as the Kahn framework suggests.  Verification has the key feature to determine 





focuses on alignment of data values with respect to external benchmarks. However, I did not 
have access to external data sources to conduct validation data quality assessment, so I only 
focused on verification (63). Additionally, I observed the need to make the definitions of my data 
quality assessment specific. I thus modified some definitions of the proportions from the ones 
that I made in my proposal. I have provided a table of the modified definitions in Appendix 5. I 
present the variables selected, specific definitions and status of any changes in definitions that I 













Value Conformance Completeness 
(Validation) 


























All patient identifiers 
issued at registration 
with matching data 
dictionary 
definition/all patient 
identifiers in the 
database 
All patient identifiers 
issued at registration 
verified at central 
database/ All patient 
identifiers issued for 
that site 
No longer assessed 
for all characteristics 
Unavailability of 
some datasets – The 
EHR component had 
not been 
implemented by the 
time of my study. 































































All patients with 
current place of 
residence matching 









All patients registered 




format/ all patients 
registered with a 
dispensation 
 
All patients with 




with master/ All 
patients with current 
place of residence 
documented at 
registration 
Made the definitions 
specific by stating the 
denominator as “All 
study patients during 
the research period” 
 
Made numerator for 
atemporal plausibility 
specific by adding 
“look up table” 
 
Added other 
plausibility type of 
Temporal plausibility 






assessment due to 
Making the 
definitions exact – 
Added population 





















Value Conformance Completeness 
(Validation) 
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prescriptions filled on 








Number of patients 
with changed regimen 
and documented 
reason at changing 
saved from domain of 
reasons/number of 
patients with changed 
regimen and 













conformance as part 
of the data quality 
assessment due to in 
part its inherent 
inclusion in the 
design of the EHR. 
Making the 
definitions exact – 
Added population 














some datasets – Did 
not analyze the 
variables on changes 
in regimens because 
the dataset was not 
provided by the 
system implementer. 
 








Number of patients 
with weight and 
height documented at 
N/A No longer 
performing 
conformance as part 
Making the 
definitions exact – 










Value Conformance Completeness 
(Validation) 





























patients with weight 
and height 
documented 
of the data quality 
assessment due to in 
part its inherent 
inclusion in the 
design of the EHR. 
numerator to be 









other sub-types of 
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I used descriptive statistics such as proportions, count statistics and charts to conduct data 
analysis for my data quality assessment as specified in Table 2.8 using the R statistical 
package(86).  
Denominator definitions formed a core part of the data quality assessment that I performed. I 
have provided the updated table definitions as Appendix 6. I operationalized the data quality 
dimensions used in the analysis above with the definitions below:  
Completeness: This was measured by assessing the frequencies of data attributes in a data set 
without reference to the data values. The restriction to assessing only the presence or absence of 
values without assessing whether these values fall in allowable limits differentiates completeness 
to plausibility. Completeness may be measured as a single instance or over several points in 
time. The time variations were applied differently based on the data variables for this study.  
I had two groups of denominators for measuring completeness in this study. The study 
population from the 10 health facilities was the denominator for the first group of variables. 
Patient physical address, patient mobile phone number and patient height fell in this group.  
Patient viral load also used site population as its denominator although only 3 central hospitals 
were selected as the population for this denominator due to availability of site data. These 
variables had the site population as its denominator because each patient is expected to have at 
least one active observation during their time of attending the ART clinic. On the other hand, I 
determined the total number of study patient visits as the denominator for variables that should 
be collected at every patient visit. These included patient weight, patient drug adherence and 
patient drug prescriptions.  
Plausibility: This deals with believability or truthfulness of values of data. Unlike completeness 
and conformance that deal with presence and structure of data values, plausibility deals with how 
closely data values represent the real world. Plausibility may be assessed in different ways: 
 Atemporal plausibility: This assesses whether observed data values meet internal expected 
values such as range checks or externally validated density distributions, such as weight for age 
checks for example. For example, weight values for adults in this case were expected only within 
a given range. Atemporal plausibility was the most common type of plausibility that I employed. 
I assessed atemporal plausibility for all variables as specified in Table 2.8 above. 
Temporal plausibility assessed whether the observed values follow expected precedence, with an 




start date. The specific definitions for the analyses that I used are in Table 2.8 above and in 
Appendix 6 and the level of plausibility was confirmed with the Malawi national guidelines for 
treating HIV/AIDS (80). 
2.6 Ethical approval 
I received ethical approval to conduct this study from the Institutional Review Boards of the 
University of Michigan Medical School (IRBMED) and the Malawi National Health Sciences 
Research Committee (NHSRC) (87). The study identification numbers for my IRBMED and 
NHSRC applications were HUM00161418 and 2341 respectively. I did not interview patients, 
hence there was no protected health information (PHI) involved for Aim 1. However, PHI was 
accessed during the extraction of patient records for Aim 2. These records were extracted by the 
by the EHR implementing organization (Baobab Health Trust) and de-identified to minimize the 
risk of compromising privacy and confidentiality of the patient records before being handed over 
to me. Additionally, I stored the collected information securely on an approved, password-






Chapter 3 Study Results 
3.1 Overview of the results section 
I present the results of my research following the methods described in Chapter 2. My project 
was a convergent mixed methods study using convergence to integrate my quantitative and 
qualitative results.  
 
3.2 Study Participants and Study population for Aims 1a and 1b 
I interviewed 34 participants for this research rather than the planned 36 because one donor and 
one public health official were not available. I interviewed stakeholders holding the roles 
described in Table 3.1 below. The roles were not mutually exclusive, as some stakeholders had 
multiple responsibilities. For example, health managers, such as health center managers, were 
usually also clinical officers or nurses. Healthcare providers were the highest number of EHR 
users I interviewed.  
Table 3.1 Study Participants 
Main EHR 
Stakeholder 




Data officer or Monitoring and Evaluation officer                 2                                                             
Health Management Information Officer (HMIS)                  1 





Clinical officer                                                                        4 
Community health nurse                                                         2 
Registered nurse midwife                                                       8 








Health Center managers                                                          2 
ART clinic coordinator                                                           2 
ART clinic manager                                                                1 
Public health officials                                                              3 













3.3 Qualitative Data Analysis Results 
3.3.1 Aim 1a: Identifying purposes of data use for different stakeholder 
My semi-structured interviews ranged from 25 to 30 minutes. After transcribing the interviews 
and defining the codebook as described in the methods chapter (Included as Appendix 3), I 
coded the transcripts into codes derived from the WHO Classification of Digital Health 
Interventions (CDHI) as purposes of data use. I observed that some purposes of data use were 
clinical facing, with linkages to direct patient care processes. Other purposes of data use focused 
on administrative end goals such as supply chain decisions. I summarized the data purposes into 
two categories. These categories were administrative purposes of data use and clinical-facing 
purposes data use, as presented in Table 3.2 below. 
 
Table 3.2 Stakeholders’ purposes of data use 
Clinical Facing purposes of data use 
WHO CDHI category Exemplar themes Exemplar Quotes 
Client identification and 
registration 
Unique patient registration and 
identification; 
“For example, the name of the 
patient is very important because we 
can have two “Mercy’s” or two 
“Elizabeths” at the same time” – 
Nurse at a health center. 
 Unique patient registration and 
identification;  
“The data helps me when doing 
patient follow-up, for example, the 
patient address” – a nurse at a 
District Hospital. 
Patient health tracking 
 
Trace patients lost to follow 
up;  
“We also have an advantage after 
seeing that data and so that, aah, we 
have a lot of defaulters in the 
program, so we entice them to come 
back to the clinic.” – Clinician at a 
District hospital.  
 
 General health tracking. - 
Maintaining the quality of care 
or improving quality 
improvement projects 
 
“For those patients who have had 
side effects; then we can know that 
these side effects that they now have 
(present with); they have improved 
from their previous side effects” – 
Clinician at a central hospital. 
 
Prescription, and medication 
management 
Give medications;  “So, we ask the question for the visit 
that they (patients) are here, we as 
well record the side effects in case 




appropriate medications as well.” – 
Nurse at a central hospital. 
 
Healthcare decision support Clinical decision support;  “To change regimens, we also use 
the same data, where we can 
actually determine whether the 
patients are failing the treatments 
after they have collected their, aah, 
viral load. And also, sometimes we 
do CD4 counts which we can enter 
into the system.” – Clinician at a 
District hospital. 
 
 Counseling decision support. “Some are young (new HIV positive 
pregnant patients), for example, 17-
year-old or 14-year-old, while some 
are older, so it helps in determining 
how to explain to these women. 
Some are older (HIV positive 
pregnant patients), and they 
understand what we are saying. “– 
Nurse at a health center 
 
Referral coordination Intra-health facility referrals;  “As I said, if there is something I 
cannot manage, I am given options 
in the same system that I should send 
the patient to the doctor. If they are 
easy things (presenting complaints), 
then the nurse can act.”- Nurse at a 
health center. 
 Inter-hospital referrals. “For example, this facility is just a 
health center, and we refer patients 
to other hospitals; for example, to 
Kamuzu Central Hospital (KCH). 
So, in the case that the patient dies, 
we can use the data to explain how 
we cared for that patient before 
being referred to them at KCH.” – 
Nurse at a health center. 
Administrative purposes of data use 
 Exemplar Themes Exemplar Quotes 
Data collection, management, 
and use 
Reporting;  “This data is important because, at 
the end of the month, we can know the 
number of women on ART treatment 
for HIV and those that are adherent. 
In the end, we can know the number 
of patients that require drugs.” – 





 Data analysis and interpretation   “The kind of more granular or visit 
level data that is more useful. So, 
one example is a discussion we have 
had recently of TB preventive 
therapy on what kind of policy 
options we might want to implement. 
There we wanted to look at the time 
intervals between initiation of ART 
and TB treatment for patients who 
develop TB because this could 
inform a strategy, we want to 
implement a preventative therapy” – 
MoH public health official. 
 
Facility management Allocation of physical 
infrastructure resources;  
“With the data, we can plan that we 
have this data we think we should 
plan for the future using available 
resources. So, we can also lobby 
other resources (like rooms, chairs, 
tables) using the data.” – A health 
center manager. 
 
 Human resource allocation “The data also helps when looking 
at the capacity of the clinic. The 
nurses, so how many nurses should 
we have in terms of the nurses, 
because we know the patients, so the 
data is helping in terms of how many 
nurses we can allocate.” – Clinic 
director at a cetre of excellence as 
donor. 
 
Supply chain management 
 
Ordering drugs or medical 
supplies;  
“In times of maybe ordering drugs; 
we need to have the number of 
people so that the drugs you order 
should be within that consignment” 
– an ART clerk at a health center.  
 
 Drugs or medical supplies 
forecasting 
“Use data for the logistics, supply 
chain management, procurement 
planning and of course including 
reporting of performance to global 
fund primarily and other funding 
sources. So, I think it’s pretty much 
the whole cycle...” - MoH public 
health official.  
 
Defining and monitoring policy Project decisions;  “Use data to inform programming of 
the baseline for a project. Key 
decisions are based on data. 




EMRs can be deployed.” – health 
manager from a MoH donor partner.  
 
 Guideline or policy Guideline 
definition or patient 
monitoring; 
“So, in that case, we made a model, 
which is a Lighthouse brand which 
we called Advanced Late and 
Unstable Patients (ALUP), which 
makes sure that we have a care 
package for such patients. So, when 
these patients come in, we make sure 
that we are packaging them to make 
sure that they virally controlled with 
treatment, enhance their nutrition, 
and at the same time we are also 
diagnosing other conditions. So for 
me, the decision of putting up a 
package of advanced HIV is coming 
in because I can see the backend of 
the data, which is coming up to say, 
what proportion of my patients are 
coming up with severe disease so 
that everyone should be well.” – 
Clinic director at a center of 
excellence as a donor. 
 
 
I have provided more detail about the findings related to the purposes of data use presented in 
Table 3.2 above in Appendix 3.  
3.3.2 Aim 1b: To identify characteristics of data quality that stakeholders using EHR data expect. 
 
I explored the concept that “data quality is fit for purpose” to establish the data quality 
characteristics that study participants required for their purposes of data use. I mapped themes of 
expected data quality characteristics to the Kahn harmonized data quality framework (63). Most 
stakeholders mentioned a group of data quality characteristics that they expect in the data that 
they use rather than pointing to a single characteristic. The group of commonly found 
characteristics included completeness, accuracy, and timeliness or currency. No stakeholder 
talked about data quality in terms of the structure of the data. This data quality characteristic is 
defined as conformance. This observation is not surprising given that conformance is more of a 
technical data quality characteristic, and the study interviewees were non-technical. I present the 
main data quality characteristic categories and themes that stakeholders mentioned as expecting 





Table 3.3 Anticipated data quality characteristics 
Anticipated Data Quality 
Characteristic Main  
Themes  Exemplar Quotes 
Completeness Accessible  
 
“Another thing, it (the data) should be 
accessible because if we have the data and 
people cannot access the data or the 
information, it will be difficult for people to 
use the data.” – Nurse at a health center. 
 
 Available “Usually, once the data is available, I am a 
clinical epidemiologist, so I try to make sure 
that you look at the completeness of the data.” 
– MoH public health official. 
 
 Available or 
representative 
“The number of health facilities that have 
submitted their reports to the district hospital 
is important. If I have 50% of the health 
facilities and also only a few reports are 
available, then it’s a problem.” – HMIS 
officer at a District Hospital. 
 Contextual 
 
“Aah ,make sure that you can define all that 
you may not find that sort of data aah; also 
qualitatively, I think or descriptively you may 
not find the data to tell you” – MoH public 
health official 
 
 Up to date or 
Current or 
Timely 
“Obviously, the first one is that timeliness is 
important. When you want to make a decision, 
you have to make sure that the data is 




“Because viral load is figures, they can all be 
recorded as normal, but it’s not the same right; 
because a count of less than 40, the other one a 
count less than 800 something, the other one a 
count of Zero,…but then all of them are 
described as suppression. Good suppression, 
but they are confusing.” – a Clinician at a 
tertiary hospital. 
 
 “The data should represent what is on the 
ground. It should not be guess-work” – a Clerk 
at a district hospital.  
 Simple “And also, it should be simple, because if the 
data is complicated, people are not able to 
understand the data it will be difficult to use 





3.3.2.1 Completeness Category 
I observed the highest repetitions of these data quality characteristics from all the stakeholders. 
Stakeholders described completeness with different themes such as availability, contextual, and 
in some cases, with either currency or timeliness. 
 
Availability 
Availability was mainly cited in the context of both clinical facing purposes of data use and 
administrative purpose of use. The responses spoke directly to the purpose of data use for 
healthcare providers, that viewed “availability” of data as enabling their roles of patient health 
tracking. 
On the other hand, administrative purposes of use tended to describe the “availability” of data by 
making sure that they have a complete dataset that should enable them to have a complete picture 
and make decisions such as the quantity of drugs to procure.  
Contextual 
I found that context was also mentioned as an anticipated data quality characteristic. I mapped 
context to the Kahn data quality characteristic of completeness. This theme of contextual data 
quality has been reported as a dimension for describing data quality before by Wang et al. and 
has also been harmonized as completeness in the Kahn Harmonized data quality framework for 
secondary data use (63,64). 
I found that for clinical facing purposes of data use such as patient assessment, the suggestion 
seemed to have a flexibility to add more details in free text about a patient’s condition.  
Timeliness or up to date 
I found timeliness mentioned concerning data being available for use to meet a purpose of use of 
any stakeholder group. Timeliness as an expected data quality characteristic has also been 
mapped to completeness in the Kahn framework. I categorized timeliness for both administrative 
purposes of data use and for clinical facing purposes of data use. Health managers for example 
view timeliness in relation to the purpose of policy or program decisions as shown in the 
example in Table 3.3 above. 
On the other hand, healthcare providers that have more clinical facing purposes of data use look 
at timeliness in relation to data being available in the EHR at the time that they want to make a 





3.3.2.2 Plausibility category 
I coded the second highest number of themes into this category. Although numerically, it came 
second to completeness, many stakeholders in describing their expected data quality 
characteristics emphasized plausibility as being important in that it would help them to correctly 
achieve their purposes of data use. The themes that were coded into this category were accuracy, 
and simplicity. Correctness was also mentioned as a theme but was mentioned alongside 
accuracy. 
Accuracy 
Stakeholders spoke of accuracy as having data that represents the true meaning of what has been 
observed. The Kahn framework maps accuracy to plausibility and describes different types of 
plausibility across three classes as described in the methods chapter. Accuracy was expected 
across the two main categories of administrative and clinical facing purposes of data use. I 
provide an illustration of accuracy as an anticipated characteristic from a clinician in Table 3.3 
above. 
Simplicity 
This theme was mentioned concerning both clinical facing and administrative purposes of data 
use. Stakeholders said their desire to quickly understand any data that is presented for their 
purpose of use. I have provided an example of one healthcare provider that performs patient 
health tracking by monitoring the patient adherence to medication, among others, as presented in 
Table 3.3 above.  
3.3.3 Aim 1c: To rank the importance of data quality characteristics by purposes of data use across 
different stakeholders using EHR and EHR data. 
I used two approaches to ascertaining the importance of data quality characteristics. 
I first asked for the importance or priority of each characteristic as an open-ended question to 
participants on data quality characteristics they anticipate in their purposes of data use. I found 
that most stakeholders could not choose a single data quality characteristic as the most important 
for their purposes of data use. They rather first responded that all of the data quality 
characteristics were very important. However, through further probing, I observed that 
stakeholders with clinical facing purposes of data use gave priority to plausibility themes 
compared to completeness. On the other hand, stakeholders mentioned completeness as the most 




observation, I could not rank the importance of data quality characteristics based on the open-
ended question that I asked during the semi-structured interviews. 
Since my study applied actual purposes of use in ART clinics for HIV/AIDS, I assessed the 
priority of the importance of data quality characteristics concerning HIV eradication goals. 
A total of 11 participants were interviewed for this Aim. Although these study participants were 
the from the same target study population for Aims 1a and 1b (34 participants), I interviewed the 
first 23 study participants for Aims 1a and 1b in a different geographical location before I had 
developed the data collection tool for Aim 1c. This is why I ended up interviewing only 11 of the 
study participants in Aim 1c (Table 3.4): 









Data officer or Monitoring and Evaluation officer                                        1   
Health Management Information Officer (HMIS)                              1 





Clinical officer                                                                                                1 







Health Center managers                                                                                1 
EHR Donors                                                                                              2 
Public health officials                                                                                      2 
  
5 
Total number of 
study 
participants 
  11 
These 11 participants formed the total number of votes across the different data quality 
characteristics pairwise comparisons of the priority of importance. I present the results of the 
data quality characteristics comparisons in Table 3.5 below based on the table from the methods 





Table 3.5 Sum of Votes and Weighted Scores for each data quality characteristic 
Comparison of 
Characteristics 
V- 1 V- 2 V- 3 V-4 V-5 V-6 V-7 V-8 V-9 V-10 V-11 Sum of 
Votes 
Purpose of use: Unique patient identification 
Plausibility 0 1 1 0 0 1 1 0.5 1 0 0.5 6 
Completeness 1 0 0 1 1 0 0 0.5 0 1 0.5 5 
Plausibility 0 1 1 0 0 1 1 0.5 1 1 1 7.5 
Conformance 1 0 0 1 1 0 0 0.5 0 0 0 3.5 
Conformance 0 1 1 1 1 1 1 0.5 1 0 0 7.5 
Completeness 1 0 0 0 0 0 0 0.5 0 1 1 3.5 
Purpose of use: Healthcare decision making 
Plausibility 0 0 1 0.5 0.5 0 0 0.5 0 1 0.5 4 
Completeness 1 1 0 0.5 0.5 1 1 0.5 1 0 0.5 7 
Plausibility 1 0 1 0 1 0 0 0.5 0 1 1 5.5 
Conformance 0 1 0 1 0 1 1 0.5 1 0 0 5.5 
Conformance 1 0.5 1 0 0.5 0 0 0.5 0.5 1 1 6 
Completeness 0 0.5 0 1 0.5 1 1 0.5 0.5 0 0 5 
Purpose of use: Viral load monitoring 
Plausibility 0 1 0 1 0 1 0.5 1 1 0.5 1 7 
Completeness 1 0 1 0 1 0 0.5 0 0 0.5 0 4 
Plausibility 1 0 0 0 0 1 1 1 1 1 0.5 6.5 
Conformance 0 1 1 1 1 0 0 0 0 0 0.5 4.5 
Conformance 0 0 0 1 0 0 0.5 0 1 0.5 1 4 





I found that plausibility had the highest importance for the purpose of the use of unique patient 
identification followed by completeness and lastly conformance. 
 I found completeness to be of the highest importance followed by plausibility and lastly 
conformance for the data purpose of use of healthcare decision making. 
I found that plausibility had the highest importance for the purpose of the use of viral load with a 
tie in the priority of importance for the data quality characteristics of completeness and 
conformance. 
My results above show variation in ranking the importance of data quality characteristics for the 
selected purposes of data use for the 90-90-90 HIV/AIDS eradication goals. This observation 
implies that stakeholders may need to consider the importance of priority assigned to different 
data quality characteristics when considering a data quality assessment or even interventions to 






3.3.2.3 Integrating Purposes of Data Use, Expected Data Quality Characteristics, and Importance of 
Data Quality Characteristics 
 
I used a side-by-side comparison of themes to integrate the qualitative results for Aim 1(72). The 
stakeholder purposes of data use are not exclusive to one data quality characteristic anticipated, 
hence the repetition. I present the integration of Aim 1 in Table 3.6 below. 
Table 3.6 Side by side theme Integration of Aims 1a and 1b 
Categories of 
Purposes of Data Use 
Reported 





of data use 
Rank of the importance of 
expected data quality 
characteristics 
Data management and 






















and monitoring policy; 






















All stakeholders were able to report data quality characteristics that they anticipate. It was clear 
that the data quality characteristics were linked to stakeholders’ reported purposes of data use. I 
found that stakeholders who mentioned clinical facing purposes of data use, expected their data 
to be plausible compared to stakeholders that mentioned administrative purposes of use. These 
stakeholders emphasized anticipating their data to be complete first to achieve their 
administrative purposes of use. My integration above showed convergence in stakeholder 
purposes of data use, expected data quality characteristics, and the priority of importance 
attached to data quality characteristics for all of the stakeholder purposes of use apart from the 
purpose of data use of unique patient identification. For this unique patient identification, 
stakeholders mentioned expecting completeness with greater emphasis but there was divergence 
in the priority of data quality characteristics. The divergence showed that stakeholders attached 




3.3.4 Aim 2: To conduct a data quality assessment of EHR data based on Kahn framework data quality 
characteristics and purposes of use in ART clinics in Malawi 
 
I present the patient study population on which I collected patient visit data for data quality 
assessment of Aim 2, in Table 3.7 below. I had a patient population of 160,647, which had 
549,826 patient visits during the study period from January 2017 to December 2018. 






















Sex     
Female 22,418 (67.0%) 24,583 (64.9%) 52,655 (58.9%) 99,656 (62.0%) 
Male 11,033 (33.0%) 13,280 (35.1%) 36,678 (41.1%) 60,991 (38.0%) 
     
Age groups     
15-24 6,736 (20.1%) 6,099   (16.1%) 9,578 (10.7%) 22,413 (14.0%) 
25-34 14,454 (43.2%) 14,477 (38.2%) 33,973 (38.0%) 62,904 (39.2%) 
35-44 8,574  (25.6%) 10,776 (28.5%) 28,686 (32.1%) 48,036 (17.6%) 
45-54 2,638 (7.9%) 4,500   (11.9%) 12,248 (13.7%) 19,386 (12.1%) 
55+ 1,049 (3.1%) 2,011   (5.3%) 4,848 (5.4%) 7,908 (4.9%) 
     
Age     
Mean (SD) 32.7 (10.6) 34.8 (10.6) 36.1 (10.2) 35.3 (10.3) 
IQR[Q1,Q3] 12[26,38] 14[27,41] 13[29,42] 13[28,41] 
 
The study population results in Table 3.7 reflect the number of patients at different health facility 
types. The health facility population sizes above match the expected catchment population of the 
health facility type. Specifically, health centers that are the smallest unit have the lowest 
population, followed by district hospitals and lastly central hospitals with the highest population.  
The gender representation of 62.0% female patients and 38.0% male patients was in agreement 
with national proportions on gender that are 64% females and 36% males (50). The study patient 
population forms the denominator for assessing the completeness of some of the variables for 
data quality assessment. These variables are the patient physical address, patient mobile number, 




since I collected viral load data only in three central hospitals, I used the population in these 
hospitals, which I have presented in Table 3.8 below:  






















Sex     
Female 9,590 (58.8%) 4,769 (62.2%) 7,851 (58.8%) 22,211 (59.5%) 
Male 6,708 (41.2%) 2,893 (37.8%) 5,508 (41.2%) 15,109 (40.5%) 
     
Age groups     
15-24 1,790(11.0%) 805   (10.5%) 1,188 (8.9%) 3,783 (10.1%) 
25-34 6,043(37.1%) 2,922 (38.1%) 4,820 (36.1%) 13,785 (36.9%) 
35-44 5,560  (34.1%) 2,442 (31.9%) 4,774 (35.7%) 12,776 (34.2%) 
45-54 2,137 (13.1%) 1,096   (14.3%) 1,955 (14.6%) 5,188(13.9%) 
55+ 768 (4.7%) 397   (5.2%) 623 (4.7%) 1,788 (4.8%) 
     
Age     
Mean (SD) 35.9 (10.6) 36.2 (10.6) 36.6 (10.2) 36.2 (10.3) 
IQR[Q1,Q3] 13 [29,42] 13 [29,42] 12 [30,42] 13[29,42] 
 
The gender and age distributions for this population of the viral load has similar proportions with 
the tertiary population in Table 3.8 above. Similarly, the proportions of age distributions are 
similar to the aggregate age proportions of tertiary hospitals in Table 3.8 above. 
I proceed by first presenting completeness of the patient visits in line with the variables for 
measuring the 90-90-90. Afterwards I present plausibility data quality assessment results.   
As expected in terms of catchment population, tertiary hospitals had the highest number of visits, 
followed by secondary health facilities and, lastly, primary hospitals. I present the breakdown of 






Table 3.9 Patient visits at different health facilities 
Health Facility Name Health Facility Type Number of Patient Visits 
 
Queen Elizabeth Central 
Hospital 
Tertiary Level 106,516 (19.4%) 
Zomba Central Hospital Tertiary Level 56,266 (10.2%) 
Kamuzu Central Hospital: 
Lighthouse 
Tertiary Level 98,950 (18.0%) 
Mzuzu Central Hospital Tertiary Level 38,640 (7.0%) 
Mangochi District Hospital Secondary Level 58,167 (10.6%) 
Dedza District Hospital Secondary Level 48,784 (8.9%) 
Nkhatabay District Hospital Secondary Level 17,193 (3.1%) 
Limbe Health Center Primary Level 55,670 (10.1%) 
Kawale Health Center Primary Level 36,173 (6.6%) 
Mapale Health Center Primary Level 33,467 (6.1%) 
Total patient visits  549,826 
 
I present my analysis of the completeness data quality characteristic for my study variables in 
Table 3.10 below.  
Table 3.10 Completeness proportions for all health facilities 
Variable Name Total number counted Denominator value Proportion 
Completeness Per 
Variable (%) 
Current patient physical 
address 
8,717 160,647 5.4 
Patient Mobile phone 
number 
89,569 160,647 55.7 % 
Height of patients 124,001 160,647 77.2 % 
Weight of patients 549,742 549,826 99.9% 
Drug Adherence  247,773 549,826 45.1% 
Prescriptions made 419,826 549,826 76.4% 
HIV Viral load 30,036 37,3204 80.5% 
 
The variables above map to the 90-90-90 efforts for eradicating HIV/AIDS by 2030 in Malawi. 
There is incompleteness in all variables, which is disturbing for the national efforts.  
For the patient retention purpose of use, which is enabled by complete current physical address 
and complete patient mobile phone number, I observe that only 5.4 % of patients have a 
 
4 This denominator is the total population of patients alive at the beginning of the study period for tertiary health 




complete physical address that may be useful for tracing patients. 55.8% have a complete mobile 
number meaning that this could potentially be used as an alternative to trace patients that missed 
their ART clinic appointments. 39% of the population in the country had mobile phone coverage 
as reported in 2018 (88). The coverage at the health facilities represents a higher proportion than 
the national average probably because these health facilities are located in urban and semi urban 
areas. Completeness of patient address was analyzed by counting records of patient addresses 
that had all components of physical address, namely: village, the traditional authority, and their 
district documented. Taking into consideration that tracing patients was a purpose of use that was 
mentioned by healthcare providers and those working in data services but had meager 
completeness proportions, I sought to understand the completeness of this variable more, as 





Figure 3.1 Analysis of individual address components 
The x-axis contains the different components of the patient physical address. The y-axis is a 
percentage of address components that have been documented for each health facility type.  
I observed that the Traditional Authority was the most undocumented component of physical 
address across all health facility types. This may be particularly high for health facilities that are 
in the city and hence the current residence of residents not being assigned to a traditional 
authority but to a ward. The health centers and tertiary hospitals were both in cities. I however 
observed a similar high proportion in undocumented Traditional Authority at the district 




address, I observed that the village is documented the highest across all health facility types with 
88% completion proportion at Health centers and 96% and 90% completion at District and 
Tertiary health facilities respectively. This observation implies that despite the meager address 
completeness rates, it should be possible to follow up on the patients that have a village 
documented and hence meet the patient tracing purpose of data use.  
Height and weight are variables that may contribute to patient retention at health facilities as they 
constitute part of standard care by facilitating the monitoring of body mass index (BMI) for 
patients enrolled in the clinic (80). I proceeded to assess their completeness since a continuous 
decline of BMI is an indicator of ART treatment failure (89,90). Treatment failure would result 
in poor outcomes of patients on treatment such as death or even patients being stopped on 
treatment to prevent further harm to the patients. This would in turn reduce the number of 
patients that are alive and retained on treatment. I observed that almost 100% of patient visits 
had a weight encounter. This finding is not surprising in the case of my study since weight is one 
of the first interactions of patients during their visit to a clinic. Almost all the study patient visits 
had a weight observation with coverage of about 99%. However, only 77.2% of patients had a 
complete height. This proportion implies that it will not be possible to calculate BMI for over 
20% of patients.  
Drug adherence is another measure that is important in the 90-90-90 target of retention. Each 
patient visit is supposed to have a drug adherence encounter documented. Only 45.1% had a drug 
adherence interaction recorded during the patient visits in this study. This result creates a 
challenge for the treatment strategy to eradicate HIV since the HIV/AIDS program will not know 
how well patients are taking their medications for over 50% of the patients enrolled in the 
program. 
The goal of the 90-90-90 target is to achieve viral load suppression in 90% of patients that have 
been retained in treatment. Viral load is a required measurement six months after a patient starts 
taking medication. I observed that 80.5% of the patient population had their viral load measured 
in the tertiary hospitals where I collected the data. Given the 90-90-90 targets, I should expect 
73% of the study population to have had their viral load measured. Since there are 37,320 
patients in the tertiary health facilities, the expected count at 73% would be 27,244. Since I 
found 30,036 patients had a complete viral load measurement, this surpasses the expectation and 




measurement and suppression (91). I explain this high finding based on the type of health 
facilities being tertiary health facilities hence being well resourced to test the viral load of 
patients. As I explained in the methods chapter, the scope of viral load records assessed in this 
study is only for three tertiary health facilities out of the targeted ten health facilities. Therefore, 
my results for viral load may only be generalized to within these three health facilities and at the 
tertiary level. 
Having assessed the completeness of the records, I proceeded to explore their plausibility. I 
present the plausibility results in Table 3.11 below: 
Table 3.11 Plausibility of various variable observations 





Per Variable (%) 
90-90-90 Purpose of Data use: Patient Tracing Variables 
Atemporal Current Patient 
Physical Address 
3,514 8,717 40.3 
Temporal Plausibility 
Patient Physical Address 
117,472 160,647 73.1 
Atemporal Patient Mobile 
Phone Number 
46,530 89,569 52.0 
Temporal Patient Mobile 
Phone Number 
89,569 160,647 55.8% 
90-90-90 Purpose of Data use: Quality of patient care 
Atemporal Weights of 
Patient 
548,825 549,742 99.8 
Temporal Weights of 
Patient 
385,480 549,742 70.7 
Atemporal Heights of 
Patient 
122,051 124,001 98.4 
Temporal Heights of 
Patient 
100,421 124,001 81.0 
Atemporal Prescription 
Made 
331,613 333,492 99.4 
Temporal Prescription 
Made 
323,924 333,492 97.1 
Atemporal Drug 
Adherence 
300,177 339,697 88.4 
Temporal Drug Adherence 212,036 339,697 62.4 
90-90-90 Purpose of Data use: Patient HIV Viral load monitoring 
Atemporal HIV Viral Load 17,286 30,036 57.6 
Temporal HIV Viral Load 29,417 30,036 97.9 
 
I calculated proportions for atemporal plausibility and temporal plausibility based on the 90-90-




My results show low proportions of atemporal plausibility for both physical address and patient 
phone number. I counted patient physical addresses as being plausible at the atemporal level if 
the documented addresses matched standard location address components in a particular district 
for a patient. This would mean validating whether a documented district in the patient address is 
indeed a district that exists first. In the next step, I assessed whether traditional authority exists in 
that district and lastly whether the village exists in that village. I counted an address as plausible 
at the atemporal level if I could validate all these components of patient address. With regards to 
the low atemporal plausibility, it means that although stakeholders may rely on phone numbers 
to trace patients that have incomplete physical addresses, they could do this accurately for only 
52.0% of the patients with a documented phone number value. Atemporal plausibility 
I, however, find that quality of care variables for BMI, such as height and weight, have high 
atemporal plausibility concerning their complete observations. This observation could be 
explained via the design of the EHR, which has built-in range checks that ensure correct data is 
entered in the system (15).  
I found that temporal plausibility varied within a range of 70% to 97% across all study variables.  
Drug adherence has atemporal plausibility of 88.4%. Plausible adherence percentages fall 
between 0 to 105% based on the Malawi treatment guidelines for HIV/AIDS (6). The Malawi 
national guidelines for the treatment of HIV/AIDS include an adherence up to 105% considering 
the scenario that some patients may come sooner than their appointment dates but with less 
medication than they should have because they either lost some drugs or shared then with 
partners. All patients that had their adherence percentage outside the possible range of 0 to 105% 
were counted as not plausible. 
I found that 57.6% of viral load patient records had met atemporal plausibility. Atemporal 
plausibility counted patients that had their first viral load measured within 5 to 36 months of 
starting ARVs.  I used such a flexible definition, considering that most patients had not yet had 
their viral load measured since the program for the viral load was being rolled out during my 
study period. Therefore, most patients had been on treatment beyond the 5 to 12 months period 
in the guideline recommendations. I thus took the maximum milestone for viral load 





3.3.5 Integrating Data Quality with Expected Purposes of Use 
I observed that purposes of use were not exclusive to stakeholder roles and the domains in which 
they work. For example, stakeholders such as public health officials and healthcare providers 
both reported purposes of data use with themes of data analysis, interpretation and reporting. I 
regarded the common unit for integrating my qualitative and quantitative results based on the 
stakeholder data purposes of use, expected data quality characteristics, ranking of the priority of 
importance of data quality characteristics, and then the results of my data quality assessment. I 
used a theme by statistics approach to integrate the qualitative and quantitative results of my 
study in Table 3.12 below.  
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As I explain my integration of the qualitative and quantitative results in the table above, I go 
back to my integration strategy where I introduced the concept of divergence or convergence of 
results. Divergence describes the situation where there is disagreement in the qualitative findings 
and the quantitative findings. The disagreement may be high expectation of a qualitative aim but 
finding low results in the quantitative aims or vice versa. Convergence on the other hand 
describes the situation where there is agreement between qualitative and quantitative results. A 
challenge that I faced were the acceptable thresholds in terms of an acceptable proportion for the 
quantitative results. 
I ranked plausibility the highest importance for the data purpose of the use of data management 
and supply chain. Taking the current place of residence and patient mobile phone number shows 
that they have 40.3% and 52.0% plausibility proportions. These results show divergence between 
expected data quality characteristics, the importance and the observed data quality assessment 
proportions. 
My comparison of integration for the next stakeholder reported purposes of data use of supply 
chain and defining policy shows some convergence between the qualitative results and the 
quantitative results. I make this observation considering that the ranked importance priority of 
the expected data quality characteristics matches their quality proportions. Although the 
prescription completeness proportion is 76.4% based on all patient visits, I make the observation 
that some of the visits may have been just patient assessments without a drug prescription being 
made and thus documented.  
The third group of purposes of use (patient health tracking, healthcare decision support, and 
referral coordination) has differing overall comparisons for the different examples of variables 




completeness and its low importance priority and the quantitative results. My data quality 
assessment found only 45.1% of adherence records being complete. 
On the other hand, for the last tracking variable of viral load, stakeholders anticipated the records 
to be plausible and complete. However, they placed higher importance on plausibility. 
Integrating these qualitative findings and the quantitative results, however, show a divergence in 
that there is low plausibility of viral load results despite high importance placed on plausibility as 





Chapter 4 Discussion and Conclusion 
I used mixed methods to answer the research question, “How do varying purposes of data use 
inform interventions for improving electronic data quality in ART Clinics in Malawi.”  
My study established that the importance of data quality characteristics was not the same across 
different purposes of health data use. I made this observation during integration of my qualitative 
and quantitative results where I found that stakeholders placed different importance on data 
quality characteristics for different purposes of use. This finding is consistent with a study 
conducted in Haiti, where stakeholders working in HIV clinics attached different priorities to 
data variables that were selected for automated audit and feedback to improve the data quality of 
EHR records at multi-site ART clinics for HIV(35). The finding of different stakeholders having 
different importance for different characteristics further suggests that data quality is indeed fit for 
purpose(63), a position that was also adopted by the study in Haiti (63). The integrated findings 
in chapter 3 have implications on how the data collected in the EHR may be used. As I have 
explained in the results, I had convergent and divergent results upon integrating quantitative and 
qualitative results. Convergent results were those that had agreement between the views 
expressed in the qualitative findings and the quantitative data. On the other hand, divergent 
results had qualitative views that did not have quantitative data to support the expected views.  
In the case of divergent findings, there may be a need to make decisions on the utility of the data 
that is available. In the example of patient tracking, there may be a need to further understand the 
extent of the plausibility of the records in order to meet the purpose of use of tracing patients and 
bringing them back into care. 
On the other hand, in the case of convergent results between the purposes of data use, importance 
priorities for data quality characteristics and the observed proportions for data quality, there may 
be greater confidence to meet the stakeholder purposes of data use.  
My convergent and divergent integration results for Aims 1 and 2 suggest implications in terms 
of key part of my research around the view that data quality is fit for purpose. In the divergent 
examples the view of data quality is fit for purpose may not hold since the user expectations do 




the source of any divergence. A suggestion could be for example, based on the stakeholder 
purpose of data use, to modify how data is documented in hope of improving a given data quality 
characteristic. 
For convergent results, the recommendation may be to continue current practices so that the 
observed data quality is maintained. 
In the context of integrating my qualitative and quantitative results, I believe that my study 
results suggest a process towards answering my research question. The finding of my study on 
different purposes of use having different importance priorities for anticipated data quality 
characteristics and the observed data quality assessment motivates me not only to consider 
previous solutions that have been implemented as possible interventions to improve data quality. 
I believe my study suggests that interventions should not be a one size fits all but should take 
into consideration several factors. These factors include: 
● Priorities of importance attached to data quality characteristics for different stakeholder 
purposes of data use.  
● The observed data quality after conducting a quantitative data quality assessment  
● Any reported barriers or facilitators that may contribute to the observed data quality.  
 
Identifying and implementing interventions that improve data quality should consider the factors 
listed above. However, since my study did not have the scope and feasibility to identify 
interventions that would be appropriate to improve poor data quality, I reviewed literature to 
identify interventions that have been implemented in similar settings.  
4.1 What are some interventions that have been implemented to improve data quality 
Introduction 
I conducted a literature review on interventions that have been implemented to improve data 
quality by searching several databases such as Google Scholar, PubMed and other reports 
recommended to me by my research committee. I proceeded on this route with the understanding 
that there have been previously reported challenges that result in poor data quality and efforts to 
improve poor data quality. Studies by Forster et al., Kumar et al., and Noureldin et al. (92–94), 
mentioned environmental challenges such as infrastructure, knowledge challenges such as the 




contributors towards poor data quality in resource-constrained settings. These studies suggested 
investing in interventions to tackle the challenges they established to improve data quality.  
Methods 
I conducted a literature review to identify journal reports with interventions to improve data 
quality in low-income countries using the Preferred Reporting Items for Systematic and Meta 
Analyses (PRISMA) guideline (95). I used the search terminology listed in the PRISMA 
checklist in Appendix 9 to identify articles for review in two databases namely Google Scholar 
and PubMed: 
 
I list the inclusion and exclusion criteria for the articles that I extracted for literature review in 
Table 4.1.  
Table 4.1:Inclusion and exclusion criteria for systematic review of interventions to improve data quality in LMICs 
Item Inclusion Criteria Exclusion criteria 
Settings Low- or Middle-Income 
Country (LMIC) setting in 
Sub-Saharan Africa  
Studies whose settings are not 
in LMICs in Sub-Saharan 
Africa  
Type of medium used Data captured in an electronic 
health record or other 
electronic health media. 
Studies that do not use 
electronic health records or 
other electronic media 
Time of publication Published from 2008 onwards 
(Taking into consideration 
that the EHR scale up in 
Malawi started in 2007) 
Studies published earlier than 
2008 
Intervention Papers that describe 
interventions to improve data 
quality. 
No description of any 
intervention to improve data 
quality. 
Language Studies conducted in English Language other than English 









I found a total of 122 articles after conducting my search in the databases specified above. I 
narrowed down articles to 15 to review further in terms of the content regarding my interest on 
interventions to improve data quality. I have included a PRISMA flow diagram in Appendix 8 
that details how I arrived at the articles that I present in Table 4.2. I categorized the different data 
quality interventions reported in the journal articles into the following main categories: 
1. Supervision as a data quality improvement intervention: I classified articles that reported 
the intervention of a supervisor checking the quality of the data into this intervention. 
2. Automated data quality assessments: I classified interventions that employed automated 
database queries for data quality assessment on existing electronic data using the 
mechanism of dashboards or reports into this category. 
3. Capacity building via training and staff recruitment: I classified all interventions that used 
training on data quality improvement approaches or used recruitment of special cadres to 
improve data quality into this intervention. 
4. Computerization of the documentation process or use of computer equipment: I classified 
all articles that reported the design and implementation of technology interventions such 
as EHRs, mobile health applications to improve data quality in one way or another. 
5. Modification of data collection tools: I classified interventions that used change of the 
structure of the data collection tools as the intervention to improve data quality. 
6. Development of standard operating procedures: I classified interventions that used job 
aides to improve data quality. 
I observed that most articles reported that they implemented a combination of interventions to 
improve data quality. I use the numeric numbers above to represent the group of combinations 





Table 4.2: List of published interventions to improve data quality in LMICs 
First Author Year Title Intervention Used Intervention 
Categories 
Scobie M.  
Heather et 
al.(96) 
2020 Improving the quality of Immunization 
and surveillance data: Summary report 
of the Working Group of the Strategic 
Advisory Group of Experts on 
Immunization. 
New electronic platforms; Routine monitoring of 
data quality; Automated validation checks and 
analyses; Data triangulation. 
4,1,2 
Karuri et al.(97) 2014 DHIS2: The Tool to Improve Health 
Data Demand and Use in Kenya. 
Using available data will improve data quality; 
Computerization of records improves data quality. 
4,1 
Abiy  et al. (98) 2018 A Comparison of Electronic Medical 
Record Data to Paper Records in 
Antiretroviral Therapy Clinic in 
Ethiopia: What is affecting the Quality 
of the Data? 
Trainings and continuous support to health workers; 
Implementation should be single EHR. 
3,4 
Mphatswe et al. 
(99) 
2012 Improving Public health information: a 
data quality intervention in Kwa Zulu-







Specific training for health-care workers on 
importance of public health information; Monthly 

















2013 Improving health information systems 
for decision making across five sub-
Saharan African countries: 
Implementation strategies from the 
African Health Initiative  
Simplified data capture and streamlined reporting 
designed to lead to more time to focus on quality; 
Ongoing feedback on missing data and outliers, and 
ongoing data quality assessments; Quarterly data 
quality audits and automated data quality report 
based on logic errors generated when administrative 
and clinical reports are generated; Facility 
supervisors review community health agent reports 
and provide data feedback; Standardized protocol 
for data capture with real time query of data gaps; 
subsequent follow up during monitoring visits. 
5,1,2,6 
Puttkammer 
Nancy et al(35). 
2017 Identifying priorities for data quality 
improvement within Haiti’s iSante 
EMR system 
Automated data quality features via validation; Data 
quality dashboard over time on automated queries.  
2 
Githinji Sophie 
et al (101). 
2017 Completeness of Malaria Indicator data 
reporting via the District Health 
Information System . 
Technical expertise from the MoH; Strong and 
robust monitoring via biannual surveys; Regular 
data reviews and technical working groups at both 





2014 Strengthening district-based health 
reporting through the district health 
management information software 
system: the Ugandan experience. 
Computerization improves data quality reporting; 





2015 Effects of a health information system 
data quality intervention on 
concordance in Mozambique:time-
series analyses from 2009-2012 (24) 
Facility based audits, targeted training and 
supervision, equipment purchase/maintenance, data 





2018 The impact of routine data quality 
assessments on electronic medical 
record data quality in Kenya 
Routine data quality assessments; Audit and 




2017 Improving data quality across 3 sub-
Saharan African countries using the 
Consolidated Framework for 
Implementation Research 
(CFIR):results from the African Health 
Initiative. 
Routine data audits linked to on going on the job 








2014 Strengthening monitoring and 
evaluation (M&E) and building 
sustainable health information systems 
in resource limited countries: lessons 
learned from an M&E task-shifting 
initiative in Botswana  
Capacity building by recruiting new roles. 3 
Admon A.J. et 
al (106). 
2013 Assessing and improving data quality 
from community health workers: a 
successful intervention in Neno Malawi  
Task shift role of data aggregation; Localization of 
data collection forms. 
3,6 
Gadabu O.J. et 
al (39).  
2011 Is transcription of data on antiretroviral 
treatment from electronic to paper-
based registers reliable in Malawi?  
Computerization of paper-based records. 4 
Elizabeth Hazel 
et al(107). 
2017 Using Data to Improve Programs: 
Assessment of Data Quality and Use 
Intervention Package for Integrated 
Community Case Management in 
Malawi  
Provision of calculators to improve accuracy of 










I discuss each of the interventions discussed in the Table 4.2 in the context of my study in the 
sections below. I further discuss how each of these interventions would be relevant for purposes 
of my study.  
 
4.1.1 Supervision as a data quality improvement intervention. 
Health facility data supervision approaches have been considered in many settings similar to 
Malawi (37,100). The general idea is that the EHR data use stakeholders need to be accountable 
to higher authorities via mechanisms such as routine data quality analyses. In Malawi, 
supervision has mostly been on HIV/AIDS data for patients enrolled in the ART program. The 
EHR programs at health facilities maintain a paper-based system as well as an electronic system. 
This model of implementing EMRs has been reported in other settings such as in Ethiopia and 
Mozambique (98,103).  The data collected via the EHR is compared against the data collected on 
paper-based records with the paper-based records acting as the gold standard most of the times 
(39). In settings outside Malawi, others have pointed out the resource intensive nature of 
supervision as a method for ensuring data quality which results in an expensive process of 
ensuring data quality (35). Regardless of cost being a barrier, the intervention of routine 
supervision is very popular and shows some results in terms of improving data quality as shown 
by the frequency it has been shown in Table 4.2. 
4.1.2 Automated data quality assessments of EHR data 
Some settings that have an EHR have proposed implementation of automated queries to assess 
data quality and generate data quality reports (35). These reports would give feedback to 
different stakeholders on variables that they should focus on and improve data quality on. For 
example, I came across a paper in an HIV clinic in Haiti where they identified important 
variables for different stakeholders to improve data quality. In this report, they advocated for 
implementation of these reports although they did not actually implement them. 
However, in another intervention in a widely used aggregate data documentation system in 
settings similar to Malawi called the District Health Information System version 2 (DHIS 2), 
data quality assessment reports are part of the system. In this setup, the data quality reports focus 
on completeness and timeliness of aggregate data reports (108). Completeness and timeliness are 




use of the reporting dashboards in DHIS version 2 in Sierra Leone during data review meetings 
led to an increase of completeness of selected indicators (97).  
I thus would recommend implementation of automated data quality tools in the setting of Malawi 
to improve the EHR data quality for different variables within the HIV/AIDS program. Given the 
experience, in other countries, such as the report carried out by Gimbel et. al (104), I would 
recommend combining the intervention of the automated reports with meeting reviews so that 
there should be stakeholder engagement. This would be important to ensure by-in by all parties 
involved as reported by Gimbel et al (104).   
4.1.3 Capacity building via training and staff recruitment 
Capacity building via targeted trainings is a common intervention for data quality improvement 
that I encountered in many of the journal articles in Table 4.2. Capacity building has been 
adopted for different types of data systems including aggregate and EHR based systems similar 
to the one I based my study in Malawi. For example in two settings with an EHR in ART settings 
in Kenya and Ethiopia, training was reported to result in improved data quality (37,98). A similar 
observation was made for aggregate data systems, where the introduction of dedicated cadres to 
enter collated data into the DHIS version 2 increased completeness of reported indicators (1,2). 
Training has further been emphasized as an appropriate intervention 
to improve understanding of the data collected and techniques for analyzing the data to improve 
data use with the hope that this would in turn improve data quality. In a study that assessed 
interventions to improve data quality in three sub-Saharan African countries namely 
Mozambique, Zambia and Rwanda, an implementation science framework called the 
Consolidated Framework for Implementation Research was used to have group discussions that 
would lead the way into identifying appropriate interventions (104). On-going on-the-job 
training was emphasized as an important intervention to ensure data quality.  
 
4.1.4 Computerization of the documentation process or the introduction of computer equipment 
Some challenges in data quality are a result of errors that arise due to the limitation of not being 
able to build in computation or validation rules in paper-based system. I reviewed papers that 
have used different levels of automation to improve data quality at different levels. In a study to 
improve accuracy of data collected by community health workers for the Integrated Management 




improve the accuracy of aggregating data before documenting this data into facility reporting 
form (107). Despite, this basic intervention, there was some improvement in the accuracy of the 
aggregated data.  In other more complex interventions, EHRs have been implemented with the 
observation of reduction in missing patient records which usually result due to damage of 
physical patient records (39). Computerization is however, also sought for as an intervention to 
improve data quality because of the possibility to build validation rules in the EHRs as seen in 
the implementation of the EHR in Rwanda  (1). In the case of my study, the observation of high 
degrees of data quality for some variables such as weight, may be an indication that there are 
robust built-in rules in the EHR that ensure the plausibility of these variables. 
4.1.5 Modification of data collection tools 
Other interventions have required that current tools that are used for data collection should be 
modified so that they easy to understand by healthcare providers and also that they have clearer 
workflows (100). For example, an intervention to improve the data quality of reported data 
translated data collection forms from English into the local language Chichewa in Malawi to ease 
understanding by community health workers (106). It is reported that this change, coupled with 
training resulted in higher completeness of forms submitted for reporting from the communities. 
Although, localization could be an example of change in structure intervention to improve the 
EHR data quality, I would aim at identifying other areas where change in the design would lead 
to better data quality. I would not localize at the level of the clinic since the Clinical Practice 
Guidelines at the level where I conducted my study are in English. Structural interventions that 
could be relevant for my study would be those around streamlining the documentation process so 
that plausible and complete data are entered in the EHR.  
4.1.6 Development of standard operating procedures 
Job aides have also been reported as interventions that result in improved data quality. This has 
been reported as presenting standardized protocols so that healthcare providers know exactly 
how to go about documentation (100). This may be similar to training; however, the difference 
may be with giving the healthcare workers job aides that they may use to fulfill data quality 
improvement interventions. One approach was to give community healthcare workers templates 
for making charts to achieve data use as well as to identify easily gaps in data quality and address 
the gaps there and then (106). As I established purposes of data use in my study, reporting was 




of job aides that would go beyond only how to use the current features of the EHR, but also to 





4. 2 How do the varying purposes of stakeholders’ purposes of data use inform interventions 
for improving data quality? 
I suggest that stakeholders’ purposes of data use, as have been confirmed with WHO 
classification of digital health interventions in my study may follow the process illustrated in 
figure 1 below:  
 
Figure 4.1: Suggested Process for identifying and Implementing Interventions for improving data quality in ART clinics 
Each intervention that may be implemented to improve data quality should be done considering 
the priority that a stakeholder has attached to the purpose of use being considered. The 
implementation should also take into consideration the observed data quality following a data 
quality assessment. The observed data quality assessment results alone are regarded as intrinsic 
data quality(63).   
To illustrate the suggested process in Figure 4.1, I give the example of the stakeholder clinical-
facing purpose of the use of tracking patient adherence which placed high importance for the 
plausibility data quality characteristic. I found that it had high plausibility but low completeness 
when I conducted the data quality assessment. In this example, there would be less emphasis to 
identify interventions to improve data quality for this variable immediately since the 
stakeholders’ purpose of data use, anticipated data quality characteristics and the importance 




On the other hand, the stakeholder client-facing purpose of use of viral load monitoring had high 
importance priority ranking for plausibility expectation and poor data quality in terms of 
atemporal plausibility. This divergence in the results emphasizes that efforts should be made to 
identify barriers towards the observed data quality and identify interventions to improve the 
observed data quality.  
 
4.3 Strengths and Weaknesses 
4.3.1 Strengths of My Study 
This study used a guideline for reporting mixed methods from an article on the Enhancing the 
Quality and Transparency of Health Research (EQUATOR) network called “Reporting mixed 
research in the field of counseling and beyond” hence has followed best practice in conducting 
and reporting mixed methods research(109). I have attached the guideline as Appendix 10. This 
study also had a large patient population selected from different health levels; thus, it was 
representative of the health facility types in Malawi. Therefore, the results of the study could 
apply to many other sites with similar settings in the country.  
 
4.3.2 Weaknesses of the study 
Nonresponse from a critical donor participant in the study was a weakness in the qualitative part 
as that participant plays a significant role in the rollout of the EHR in Malawi. To address this 
weakness, future work may consider engaging the donor with the results of this study to get their 
feedback. This weakness affected my first two studies which were fell under Aim 1. I take this as 
a major weakness given the background that EHR investments in Malawi are funded by this 
main donor. 
Trustworthiness for the qualitative arm of my research was also a major weakness due to the fact 
that I was the only person that conducted the coding. I tried to improve the trustworthiness of my 
coding for Aim 1 by among other things taking some time off between coding sessions. Multiple 
coders are recommended so that a researcher may report Intercoder Reliability (ICR) alongside 
reported codes.  
Another limitation I faced was the reduction in the number of participants for Aim 1c due to 
feasibility, related to the delay in completing the questionnaire used for this aim. The reduced 
number reduces how representative the results are, because I did not get views from other 




Another major limitation was the failure to get viral load datasets for health centers and district 
hospitals because they had not been documented in the EHR. To address this weakness, I 
selected records from Tertiary level hospitals since these had complete records. In future work, 
efforts would be made to replicate the study for the other health facilities.  
4.4 Possible Future Work 
4.4.1 Conduct follow up implementation study using the data quality assessment results to identify 
barriers and facilitators to data quality improvement interventions 
The data quality assessment results may be a tool that can help in bringing discussions among 
different stakeholders to identify barriers or facilitators of observed data quality. This would be 
achieved by presenting the data quality assessment results to different stakeholder groups. I 
would use implementation science frameworks to understand any barriers or facilitators that may 
have contributed to the observed data quality, specifically the Theoretical Domains Framework 
(TDF) and the Consolidated Framework for Implementation Research (CFIR) to identify 
individual and group barriers or facilitators respectively. I would use the TDF with the 
observation that there may be some factors that affect individual stakeholders as barriers or 
facilitators that result in poor data quality. These factors would best be understood by the TDF 
since this framework has dimensions and constructs that are applicable at the individual level. In 
the case of my study setting, there may be for example different cadres that have different 
individual views on their data documentation roles versus their professional roles. That being 
said, I also recognize that the individual stakeholders usually work in a group under different 
organizations. This means that there would be organizational or group facilitators or barriers 
towards data quality such as workplace regulations or culture that would need to be established. 
The CFIR has dimensions and constructs that are applicable to groups or organizations. 
 Having done this, I would then use the Behavior Change Technique Taxonomy to identify 
interventions for improving data quality(57). I would consider these interventions together with 
appropriate implementation strategies to add more structure and scalability of the interventions to 
additional health facilities. I would use the data quality assessment proportions as performance 
measures to monitor any changes in data quality over an agreed-upon time with the different 
stakeholders. I propose to conduct this as an implementation study so that changes may be 




4.4.2 Automate Data Quality Assessment in health facilities with the EHR 
Future work for this would be to automate the data quality assessment that I have conducted in 
this study and implement it in all health facilities that have Baobab Health Trust EHR. This may 
be done by packaging the processes of data extraction and analysis into one software program 
that may then be installed in all health facilities with the EHR. The software would then be set to 
run at a scheduled time and disseminate the results to selected stakeholders. This would result in 
building blocks I believe would not only give a state of data quality but would be an intervention 
to gradually and consistently improve data quality as routine supervision since manual audits are 
labor-intensive and expensive (8,35). 
4.4.3 Introduce automated tools for addressing identified poor data quality issues.  
Understanding the nature of missing data in case of completeness data quality characteristic may 
assist in addressing the poor data quality. Missing data may be classified as missing completely 
at random (MCAR), missing at random (MAR) and missing not at random (MNAR). 
I observed that some variables are missing not at random (110), such as patient physical 
addresses that consistently have village and district but do not have any traditional authority 
value. In this case the missing address component may most likely be due to the location where 
the patient lives (urban vs. rural). This is an incomplete address that may be fixed by imputing 
the missing traditional authority from lookup tables. Another example could be a patient visit 
with missing height or weight value. Again, in this example the missing data may be imputed 
from previous weight or height values for this individual or from weight and height distributions 
of patients in the cohort at that clinic if there are no previous values for an individual. 
4.4.4 Develop a website that shows DQA metrics for each health facility with an ART EHR  
Robust data quality increases data use (35). I have additionally demonstrated that different 
stakeholders using EHR ART data in Malawi have different purposes of data use. Therefore, 
consideration for future work is to build health information infrastructure for assessing data 
quality that recognizes different stakeholders. Given the process illustrated in figure 1, the job 
might entail designing a web-based tool for the MoH where stakeholders may select their 
purposes of data use and run a data quality assessment. To ensure that the tool meets various user 
needs, further steps would be employed to gather requirements around the infrastructure. These 
requirements would then inform use cases that would map to the data workflows of different 




kind of infrastructure could be customized for other similar settings and used by similar 
stakeholders. 
4.5 Conclusion 
My study has made two main contributions to understanding data quality in ART clinics for HIV 
patients in low-income countries that have EHR infrastructure. The contributions are: 
1) Process for conducting data quality assessment and follow up process to identify 
interventions 
My study has contributed methods for conducting data quality assessments and 
identifying interventions to improve any observed data quality. Taking the qualitative and 
quantitative findings, my research presented an approach to conducting data quality 
assessment and a process for answering the research question of identifying interventions 
for improving data quality in resource-constrained settings. 
2) Provide data quality assessment software code that may be adapted to present 
performance measures for displaying 90-90-90  
The second contribution is a quantitative analysis program that may be re-used to 
understand data quality for other health facilities in Malawi. The source code is freely 
available on GitHub, although it requires customization. 
Lastly, the previously reported challenges of EHR data quality in ART clinics in Malawi present 
a threat to continued rollout of the EHR as infrastructure for the ART program in the country. 
This threat could lead to loss of trust(8) in EHR data. EHR infrastructure may be a crucial part of 
creating a learning health system for ART clinics, and my study may provide necessary 
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Appendix 1: Semi Structured Data Collection Tool 
Data Quality and Fitness for Use in ART clinics for HIV/AIDS using Electronic Medical 




The purpose of this study is to understand the uses of data for different roles directly or indirectly 
linked with the EMR in Malawi. The semi-structured interviews will attempt to understand 
"fitness to purpose" of data based on these uses. Participation in the study is completely 
voluntary and participants may stop at any time in the study. The study has minimal risk to the 
participants with confidentiality being the main risk. To minimize this risk, the study will not 
collect identifiable information and will keep the recordings of the study in a separate file. The 
study will also collect at least 6 participants for each stakeholder to increase confidentiality of 
the responses provided. 
 
Question 1 

















When using the data in your work, what characteristics do you anticipate in your data? Do you 










When you think of data quality, what characteristics or features of the data do you think are 
important for your uses?  (Potential follow-up questions:  For example, is accuracy important?  Is 





Given that you have an electronic medical record system, what has been your experience with 









Now I would like to show you a list of uses suggested by other people with a role similar to 
yours.  Do you think these uses apply to your role in organization? 
 
 
Table 4.3 Adapted from the WHO digital classification of health interventions 
Stakeholder Purpose of data use 
Healthcare providers Laboratory and diagnostics imaging management 
 Prescription and medication management 
 Healthcare provider training 
 Healthcare activity planning and scheduling 
 Referral coordination 
 Client identification and registration 
 Client health records 
 Healthcare provider decision support 
 Telemedicine 
 Healthcare provider communication 
 Healthcare provider feedback 
Health system managers Facility management 
 Health financing 
 Human resource management 
 Supply chain management 
 Public health event notification 
 Civil registration and vital statistic 
 Equipment and asset management 
Data services Data collection, management and use 
 Data coding 
 Location mapping 








I would also like to show you a list of data characteristics suggested by other people, not 
necessarily working in health care or in roles like yours.  Are these characteristics important to 
you when you use data?  Which are most important?   
 










Appendix 2: Template Analysis Table for Coding Purposes of Data Use informed by the WHO 
Classification of Digital of Health Interventions 
 
 
Table 4.4 Definition of codes for purposes of data use 
Purpose of data use category 
from the WHO CDHI 
Description Themes 
Data collection management 
and use 
Approaches to data 
collection, management, 
analysis, storage. This can 
include standalone 
interventions focusing 
exclusively on data 
collection and 
management, as well as 
data services to support 
other interventions, such as 
data visualization within 
supply chain management 
  
Identify phrases that may 
map to this category 
Client identification and 
registration 
Client identity verification 
and enrollment into health 
services. 
 
Identify phrases that may 
map to this category 
Facility management Digital approaches that 
enable administrative 
functions related to the 
management of facilities. 
 
Identify phrases that may 
map to this category 
Patient health tracking The use of health records, 
review and track health 
status. 
  
Identify phrases that may 




Prescription and medication 
management 




orders and monitoring 
physical consumption of 
medication. 
Identify phrases that may 
map to this category 
Supply chain management Approaches for monitoring 
and reporting stock levels, 
consumption and 
distribution of medical 
commodities. This can 
include the use of 
communication systems 
(e.g. SMS) and data 
dashboards to manage and 
report on supply levels of 
medical commodities.  
 
Identify phrases that may 
map to this category 
Defining and monitoring policy Approaches to use data to 
suggest policies and 
monitor their 
implementation 
Identify phrases that may 
map to this category 
Healthcare training  The management and 
provision of education and 
training content in 
electronic form for health 
professionals [2]. In 
contrast to decision 
support, healthcare 
provider training does not 
need 
 
Identify phrases that may 
map to this category 
Human resource management Digital approaches to 
manage the health 
workforce, including the 
use of databases to record 
training levels, 
certifications, and 
identification of health 
workers. 
 
Identify phrases that may 




Client identification and 
registration  
Client identity verification 
and enrollment into health 
services 
 
Identify phrases that may 
map to this category 
Healthcare provider decision 
support  
Digitized job aids that 
combine an individual’s 
health information with the 
health-care provider’s 
knowledge and clinical 
protocols in order to assist 
health-care providers in 
making diagnosis and 
treatment decisions.  
  
Identify themes that may 
map to this category 
Referral coordination  Approaches to support 
communication and 
coordination mechanisms 
to facilitate referrals, both 
within the health sector 
and to other health-related 
sectors 
  
Identify themes that may 







Appendix 3: Template Analysis Table for Identifying Expected Data Quality Characteristics Informed 
by the Kahn Data Quality Framework for Secondary Data Use. 
 
Table 4.5 Definition of codes for expected data quality characteristics 
Kahn Framework Category Description Theme 
Conformance This focused on the 
agreement of the data against 
internal or external 
formatting, relational, or 
computational definitions. 
This characteristic did not 
attempt to measure the 
completeness or plausibility 
of the values observed 
Identify phrases that may 
map to this category such as 
concordance, correctness, 
consistency, conformance. 
Completeness This was measured by 
assessing the frequencies of 
data attributes in a data set 
without reference to the data 
values. 
Identify phrases that may 
map to this category such as 
representative, density, 
timeliness or currency, 
completeness. 
Plausibility This deals with believability 
or truthfulness of the values 
of data. Unlike completeness 
and conformance that deal 
with the presence and 
structure of data values, 
plausibility deals with how 
closely data values represent 
the world. 
Identify phrases that may 
map to this category such as 











Appendix 4: Questionnaire for Ranking Importance of Data Quality Characteristics in Relation to the 





























Appendix 5: Data Extraction table structures 
 
1. Patient identification (for patient tracking) for the Second 90 
Table 4.6 Fields extracted for First 90 
Pseudo_Patient_ID Pat_Current_Residence Pat_Phone_Number Pat_age 
    
 
2. Patient care data: Drugs Dispensed for the Second 90 
Table 4.7 Fields Extracted for Second 90, Drugs Dispensed 
Pseudo_Patient_ID Patient_Visit_Date Prescribed_Drug Dispensed_Drug Quantity 
Dispensed 
     
 
Patient care data: BMI calculation for the Second 90 
Table 4.8 Fields Extracted for Second 90 BMI 
Pseudo_Patient_ID Patient_Visit_Date Patient_Height Patient_Weight Pat_age 
     
 
Patient care data: Adherence data for the Second 90 
Table 4.9 Fields Extracted for Second 90,  Drug Adherence 












      
 
3. Patient care data for the third 90: Viral Load Suppression 
Table 4.10 Fields Extracted for Third 90, Viral Load 
Pseudo_Patient_ID Date_Started_ART Patient_Visit_Date Patient_VL_Result 





Appendix 6: Detailed Updated definitions of Variable Proportions for Aim 2a. 
 









Patient tracing Patient Address 












registered with a 
current place of 
residence/all study 
patients registered 










within the study 
period.  
All complete addresses 
in look-up master 
address table /all 
patients with a 
complete physical 




All patients registered 
with the expected 
sequence of mobile 
phone number (correct 
carrier prefix) / All 
patients registered 
with a complete phone 
number 
All patients with 
physical address 
registered on or 
after enrolling in 
ART program / all 
patients with a 
complete physical 
address current 
place of residence 
 
All patients with 
mobile phone 
number registered 
on or after enrolling 
in ART program / 
all patients with a 
complete physical 
address current 



















visits/number of all 






Number of patients 
with patient 
adherence visits/ 
Number of all 




quantity of drugs 
dispensed for 30 to 90 
days duration/number 
of dispensations made 
during study period. 
 
 
Number of patients 
with adherence in 
percentage to drugs 
between 95 to 105/ 
Number of patients 
Number of patients 
that had their ARVs 
dispensed on their 
visit date/number 
of dispensations 






Number of patients 
that had their 
adherence 




 with adherence 
observations 
visit date/ number 
of patients with 
adherence 
observations 
 Body mass 
index – weight 
and height 
Number of patients 
with height visits 
/  




Number of patients 
with weight visits 
/  
Number of all 
patient visits during 
study 
Number of patient 
observations with 
height that is within 
bounds (height for age 
and absolute values)/ 
Number of patients 





Number of patients 
with weight that is not 
out of bounds 
according to weight 
for age and absolute 
minimum and 
maximum values/ 
number of patients 
with complete weight 
observations 
Number of patient 
height observations 
made on the same 
day of the patient 
visit / Number of 







Number of patient 
weight observations 
made on the same 
day of the patient 







Number of patients 
with one 
observation of viral 
load result 
 /  
  Number of study 
patients 
Number of patients 
whose viral load was 
measured between 6 to 




Number of complete 
viral load 
measurements 
Number of patients 
with viral load 
values not 
measured before 















Appendix 7: Additional Details for Qualitative Analysis of Aim 1a. 
3.3.1.1 Client Identification and Registration 
I observed that most interviewees started their description of their purposes of data use with 
patient registration and patient identification. I coded the theme of patient registration and 
identification under the WHO category of client identification and registration.  
Unique identification was emphasized as an essential purpose of data use to ensure that care is 
being given to the correct patients. The example in the table above shows the possibility of 
duplicate patients that may not receive the right care in the event of wrong identification. 
Another purpose for conducting patient registration and identification is to facilitate follow up of 
patients if a patient has missed their appointment date at the ART clinic. I found the patient 
follow up in responses for other purposes of data use, such as patient health tracking that I have 
presented below. The purposes of data use of client identification and registration are essential 
for both the first 90 in the identification of HIV positive patients and the 2nd 90 in ensuring that 
patients are retained in care.  
3.3.1.2) WHO CDHI category, Patient health tracking 
Two main themes were coded into this category and were reported mainly in the stakeholder 
groups of health care providers and data services. This purpose of data uses maps to the second 
90 in the 90-90-90 initiative of eradicating HIV/AIDS by 2030. The second 90 intends to retain 
90% of all patients enrolled in an ART clinic for HIV(11). Therefore, this data purpose of use 
links with the targeted quantitative data quality assessment of variables that enable using data to 
meet this purpose. I established the themes below under this category: 
Trace patients lost to follow up 
Stakeholders mentioned that they use data for this purpose to identify patients that had missed their 




cared about getting patients back into therapy so that they continue to receive medication.   
The choice of the word “entices” emphasized the more exceptional picture that healthcare 
providers may have on maintaining the patients into care. On the other hand, data services 
stakeholders use data to trace patients mainly to update patient outcomes with the real picture of 
who is present at the clinic. The real picture helps them in collecting the correct number of drugs 
for a clinic day from the pharmacy.  
Maintaining quality of care or improving quality improvement projects 
I coded the theme of quality improvement into the main category of patient health tracking as 
well. I observed that this theme was mentioned frequently and emphasized as a purpose of data 
use. This theme maps to the 2nd 90 as well as the 3rd 90 in HIV eradication the goals. I found that 
the stakeholder groups that emphasized this theme were healthcare providers and health 
managers. Healthcare providers, mentioned their desire to manage patient side effects properly 
which improves the quality of life of patients(12) and therefore improves retention in health 
facilities   
3.3.1.3 WHO CDHI category, prescription and medication management 
 
I found this category with mainly stakeholders such as clinicians and nurses. In a task shifting 
environment, nursing staff also reported being responsible for prescription (13). This purpose of 
data use is important for the 2nd 90 of retention since the strategy for eradicating HIV/AIDS by 
2030 is via treatment (14). Therefore, using electronic data for the purpose of prescription and 
medication management gives a basis for the data quality assessment that this study did as well. I 
found the theme below under this category: 
Drugs to prescribe based on presenting conditions 
 
Healthcare providers indicated that they use data to understand whether the patient has any 
conditions that require changing them the medication that they are on or maintaining them on the 
medication.   
3.3.1.4 WHO CDHI category, Healthcare decision support 
This formed as a category for interviewee responses that fit to the themes of clinical decisions 




clinics since they speak to the HIV targets in the country for retention as well as viral load 
monitoring (11).  
Clinical decisions 
Healthcare providers such as clinical officers gave this purpose of data use as an example of how 
they make decisions regarding management of patients who seem to be failing on treatment. 
Continued rising of viral load in the presence of ARV treatment may indicate ARV treatment 
failure. Viral load is measured in copies/ml of blood to understand the extent of HIV disease in 
patients. Viral load is the leading guide for clinicians to make crucial decisions on management 
of the patient in case of rising viral load. The recommended viral load for patients to remain 
healthy and reduce morbidity due to HIV opportunistic infections, is below 1000 copies/ml(6) 
and this is considered viral load suppression. Patients that have less than 40 copies/ml are 
considered to have undetectable HIV hence no risk of sexually transmitting the virus to their 
partners (6)(15). The goal of eradication is, therefore, to ensure that 90% of patients on ART for 
HIV achieve viral load suppression and having this as a purpose of data use confirms the need 
for these data. I also performed a data quality assessment for viral load quantitatively, and the 
results are in the next section. 
Counseling decisions 
This theme appeared as a purpose of data use with the example of making sure that patients are 
given the right education in terms of procedures they receive. Healthcare providers indicated that 
they reference data such as patient age to know how much emphasis they should put on their 
counseling efforts.  
Counseling is vital as a purpose of data use, particularly in the context of this study since patients 
receive counseling triggered by different data points such as the proportion of drugs that are 
calculated to have been taken concerning their previous clinic visit.  Adherence is one of the 
variables that this study analyzes regarding the 90-90-90 target of patient retention. Counselling 
has also been shown to be one of the factors that influence patients, particularly in ART settings, 
to continue seeking care at health facilities. The importance of counseling was confirmed in a 
study that assessed factors of retention for pregnant women started on lifelong antiretroviral 





I coded referral coordination with two themes of intra-hospital referrals where healthcare 
providers indicated that they use data as a means of referring patients that require additional care 
to more experienced doctors. This type of referral would usually happen within the same health 
facility. Additionally, healthcare providers touched on the data purpose of the use of transferring 
patients to more resourced health facilities such as tertiary health facilities. This purpose of data 
use is consistent with the expectation of smaller health facilities, referring patients to more 
prominent and well-resourced health centers. An interesting point raised as part of the response 
is the view that the documented care at the source health facility may be used for legal purposes 
if there is an adverse outcome for the referred patient such as a death. 
3.3.1.5) WHO CDHI category, Data collection, management, and use 
 I found this as a common category for all stakeholders. Although this category was common 
across all stakeholders in this study, the themes varied. I found that this finding echoed previous 
research on the goal of implementing EHRs, where the primary purpose of the data collected was 
mainly for generating routine reports (17). Some of the themes that emerged under this category 
were: 
Reporting 
Many healthcare providers mentioned reporting as an essential purpose of data use about the EHR 
systems that they use. However, a closer assessment of “reporting” as a theme under the category 
data collection, management, and use, reveals it as a means to an end in terms of the actual 
professional roles of the stakeholders. For example, clinical facing stakeholders such as clinicians 
and nurses valued reporting to aid them in their daily work such as knowing the correct number of 
patients in their clinics so that they may prepare how to treat them, 
On the other hand, stakeholders in data services cared more about data collection, management, 
and use to submit routine reports to the MoH. This view was also true for other stakeholder roles 
involved in administrative activities that mentioned the theme of reporting as fulfilling a routine 
requirement to an external body. 





I found the theme above mainly in the stakeholder roles of health managers, such as the MoH 
officials or EMR donors. I also found that advanced data service roles such as data officers and 
monitoring and evaluation officers also mentioned this as their purpose of data use. Most of the 
time, this was referred to as data analysis to understand certain national interest conditions and 
inform planned interventions on the part of national programs. 
Within the data services stakeholders, there were data officers or monitoring and evaluation 
officers that mentioned data analysis in the context of cleaning data and responding to questions 
that their supervisors would want to answer based on the data being collected.  
3.3.1.6 WHO CDHI category, Facility management 
This was also a primary purpose of use for health managers at different levels of the healthcare 
system in Malawi. Health managers, those that oversee health facility activities cited examples of 
data use that affected their immediate needs such as staffing requirements or need for 
infrastructure. The WHO CDHI has human resources as an area with examples of digital health 
interventions. Since human resources in this study were mentioned as an example of a data 
purpose of use in the context of facility management, I coded it under health facility 
management. The end goal of adequate resources at health facilities may speak directly to the 
issue of retention of patients since inadequate staff members and resources have been shown to 
affect optimal care to patients and thus potentially reduce retention of patients (18)(16)(19).   
The themes that appeared under this category are, therefore: 
Allocation of physical infrastructure 
Health managers at facilities cited that they use data to demonstrate the need for additional 
infrastructure since most of them receive equipment to use via the standard classification of the 
health facility. So, if a health facility is a health center, they will have designated number of 
rooms and specific equipment that is expected to be available in such places. A nurse who is the 
in-charge of one of the health centers attested to this. 
Human resource management 
This was another common theme that went beyond adequate numbers of members of staff for 
different departments at a health facility but also using data to understand the various training 
needs of the staff.  




patients are receiving care according to national clinical practice guidelines for the management 
of HIV/AIDS (20). Human resource capacity, in turn, ensures that patients are getting good 
quality care, which provides progress towards the goals of HIV eradication. 
3.3.1.7 WHO CDHI category, supply chain management 
All stakeholders mentioned a supply chain theme as one of their purposes of data use. Supply 
chain management was mentioned as an end goal for collecting data using the EHR. Two main 
themes appeared here. One for healthcare providers and staff working at health facilities such as 
data services. The other more for public health officials focusing on the national and sub-national 
scales. 
Ordering drugs or medical supplies 
This theme was a purpose of data use that was mostly reported by stakeholders working at sub-
national levels, such as health facilities. I found these stakeholders to be mainly healthcare 
providers such as nurses and those in data services such as data clerks. Ordering of drugs, in this 
case, meant requesting drugs from their facility drug store to their clinic to dispense to patients 
during clinic time. For data services people who collect and transport the drugs from the drug 
storeroom, they want to receive the right quantity. 
On the other hand, for health managers who would be clinic managers or public health officials, 
their purpose of data would target ensuring population-level availability of drugs at different 
scales of national and facility levels. The availability of drugs is a crucial feature of the national 
ART program in Malawi as there is a robust supervision model to ascertain patient outcomes 
every three months (21).  
Drug forecasting 
Drug forecasting was another theme that appeared mainly in health managers working at the 
national level. Faced with challenges in timely reporting, one essential technique that I got from 
the interviewees is to use available data to estimate quantities of ARV drug regimens that are 
required for the national program.  
To an extent, the different purposes of data use reported seem to support the supply chain of 
various commodities as the end goal, particularly for HIV being a chronic illness that requires 
taking ARV drug regimens daily. 




Defining and monitoring policy was almost exclusively for health managers with other staff 
accepting their roles as only supportive in the way they use the data. For example, data services 
indicated that they produce data for decisions that are made at senior management levels. I feel 
this purpose is relevant to this study because the stakeholder group of healthcare managers 
makes decisions about the EHR in the country. I found the themes below: 
Project decisions 
The purpose of data use of project decisions pointed to the application of electronic data to help 
in defining specific interventions driven by the MoH partners or by the ministry itself. An 
example from one respondent was on how they use data to make decisions on scaling the EHR in 
the country. 
Project decisions such as reported here are not strange as there have been other decisions that 
started as projects on a smaller scale based on data but were eventually scaled up in the country. 
An example is an initiative to enroll all women that test HIV positive immediately on ARVs, 
which began with a few health facilities as a project and then scaled nationally (22). 
Guideline definitions or patient monitoring 
Guideline definitions or patient monitoring was another common theme for data use with health 
managers such as public health officials within the MoH and clinic partners at specialized clinics 
that serve as centers of excellence for treating HIV/AIDS.  
Other stakeholders mentioned this theme in line with using data to understand currently 
implemented guidelines and then making suggestions on how best to improve them. I observe 
here that this data use is also crosscutting with the category of data collection, management, and 
use mainly the data analysis and interpretation theme, which would then lead to new ways of 
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Appendix 9: PRISMA Checklist(95) 
Table 4.12 Checklist for PRISMA literature review 
Section/topic  # Checklist item  Reported on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  77 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data 
sources; study eligibility criteria, participants, and interventions; study appraisal and 
synthesis methods; results; limitations; conclusions and implications of key findings; 
systematic review registration number.  
77,78 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  77 
Objectives  4 Provide an explicit statement of questions being addressed with reference to 
participants, interventions, comparisons, outcomes, and study design (PICOS).  
77 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web 
address), and, if available, provide registration information including registration 
number.  
N/A 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report 
characteristics (e.g., years considered, language, publication status) used as criteria 
for eligibility, giving rationale.  
78 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with 





Search  8 Present full electronic search strategy for at least one database, including any limits 
used, such that it could be repeated.  
PubMed: ((((((Data quality improvement interventions) AND (electronic health 
data)) OR (health information systems)) OR (digital health)) AND (Low 
Income Countries)) OR (developing countries) ) OR (LMICs) 
Google Scholar: "Data quality interventions" for electronic health data or 
health information systems  Low Income Countries 
 
 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in 
systematic review, and, if applicable, included in the meta-analysis).  
78 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in 
duplicate) and any processes for obtaining and confirming data from investigators.  
Independently 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding 
sources) and any assumptions and simplifications made.  
78 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including 
specification of whether this was done at the study or outcome level), and how this 
information is to be used in any data synthesis.  
N/A 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  N/A 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, 






Appendix 10: Guidelines for Conducting and Reporting Mixed Research (111) 
Table 4.13 Checklist for Conducting Mixed Methods Research 
1. Research Formulation  Page Number 
  
1.4.1. Specify the purpose of the study.  
19 
1.4.2. Specify the purpose for combining qualitative and 
quantitative approaches (e.g., identify representative 
sample members, conduct member check, validate 
individual scores on outcome measures, develop items for an 
instrument, identify barriers and/or facilitators within 
intervention condition, evaluate the fidelity of implementing 
the intervention and how it worked, enhance findings that 
are not significant, compare results from the quantitative 
data with the qualitative findings). 
3, 30 




1.5.2. Present mixed research questions (i.e., questions that embed 
both a quantitative research question and a qualitative 
research question within the same question) when possible. 
19 
  
2. Research Planning   
  
2.1.1. Specify the initial and final sample sizes for all 
quantitative and qualitative phases of the study. 
 
37,44,49 
2.1.2. Present all sample size considerations made for the 
quantitative phase(s) (i.e., a priori power) and qualitative 
phases (e.g., information-rich cases). 
49 
2.1.3. Present the sampling scheme for both the quantitative and 
qualitative phases of the study. 
 
38,44,49 
2.1.4. Describe the mixed sampling scheme (i.e., concurrent–
identical, concurrent–parallel, concurrent–nested, 
concurrent–multilevel, sequential–identical, sequential–
parallel, sequential–nested, and sequential–multilevel). 
31 
2.1.5. Clarify the type of generalization to be made (i.e., 
statistical generalization, analytic generalization, and case-
to-case transfer) and link it to the selected sampling 
design, sampling scheme, and sample size(s). 
 
2.2.1. Outline the mixed research design. 31 
2.2.2. Specify the quantitative research design (i.e., historical, 
descriptive, correlational, causal–comparative/quasi-
experimental, and experimental). 
38,44,48 
2.2.3. Specify the qualitative research design (e.g., biography, 
ethnographic, auto-ethnography, oral history, 






3. Research Implementation   
  
3.1.1. Outline the mixed data collection strategy. 31 
3.1.2. Present information about all quantitative and qualitative 
instruments and the process of administration. 
39,44,48,50 
3.2.1. Outline the mixed data collection strategy (i.e., data 
reduction, data display, data transformation, data 
correlation, data consolidation, data comparison, and data 
integration). 
32 
3.2.2. Provide relevant descriptive and inferential statistics for 
each statistical analysis. 
50,52 
3.2.3. Discuss the extent to which the assumptions (e.g., 
normality, independence, equality of variances) that 
underlie the analyses were met, as well as any 
observations that might have distorted the findings (e.g., 
missing data, outliers). 
NA 
3.2.4. Specify the statistical software used. 56 
3.2.5. Specify where the responsibility or authority for the creation 
of categories resided (i.e., participants, programs, 
investigative, literature, or interpretive), what the grounds 
were on which one could justify the existence of a given set 
of categories (i.e., external, rational, referential, empirical, 
technical, or participative), what was the source of the name 
used to identify a given category (i.e., participants, 
programs, investigative, literature, or interpretive), and at 
what point during the research process the categories were 
specified (i.e., a priori, a posteriori, or iterative). 
40, 42 
3.2.6. Specify the name of the technique used to analyze the 
qualitative data (e.g., content analysis method of constant 
comparison, discourse analysis, componential analysis, 
keywords in context, analytic induction, word count, 
domain analysis, taxonomic analysis). 
40 
3.2.7. Specify the qualitative software used. 40 
3.3.1. Discuss the threats to internal validity, external validity, and 
measurement validity and outline the steps taken to address 
each of these threats to internal validity, external validity, 
and measurement validity. 
39,35 
3.3.2. Discuss the threats to trustworthiness, credibility, 
dependability, authenticity, verification, plausibility, 
applicability, confirmability, and/or transferability of data 
and outline all verification procedures used. 
40 
3.3.3. Discuss mixed research legitimation types (i.e., sample 
integration legitimation, insider–outsider legitimation, 
weakness minimization legitimation, sequential 
legitimation, conversion legitimation, paradigmatic mixing 
legitimation, commensurability legitimation, multiple 
validities legitimation, and political legitimation). 
 
33,74,82 
3.4.1. Interpret relevant types of significance of the quantitative 





clinical significance, and economic significance). 
3.4.2. Conduct post hoc power analysis for all statistically 
nonsignificant findings. 
NA 
3.4.3. Interpret the significance (i.e., meaning) of qualitative 
findings. 
NA 
3.4.4. Discuss criteria for evaluating findings in mixed research 
studies (e.g., within-design consistency, conceptual 
consistency, interpretive agreement, interpretive 
distinctiveness, design suitability, design fidelity, analytic 
adequacy, interpretive consistency, theoretical consistency, 
integrative efficacy). 
82,98 
3.5.1. Describe all steps of the mixed research process.  
3.5.2. Describe the context in which the mixed research study took 
place. 
32 
3.5.3. Ensure that the mixed research report is accurate and 
complete; does not distort differences within and among 
individuals and groups; is free from plagiarism or 
misrepresentation of the ideas and conceptualizations of 
other scholars; and contains findings that are adequately 
accessible for reanalysis, further analysis, verification, or 
replication. 
82 
3.5.4. Present all ethical considerations that were addressed in the 
study (e.g., informed consent, confidentiality, incentives, 
funding sources, potential conflicts of interest, biases). 
57 
3.5.5. Specify study approval in accordance with an institutional 
review board either in the report or in the cover letter 
submitted to the editor. 
57 
3.5.6. Present recommendations for future research that culminate 
in a validation, replication, or extension of the underlying 
study. 
104 
  
 
